Last active
December 17, 2015 08:39
-
-
Save jbedo/5582082 to your computer and use it in GitHub Desktop.
List of PLOS One categories
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
100.10.100.10.10: Biological fluid mechanics | |
100.10.100.10.20: Bone and joint mechanics | |
100.10.100.10.30: Cell mechanics | |
100.10.100.10: Biomechanics | |
100.10.100.20: Bone | |
100.10.100.30: Cartilage | |
100.10.100.40: Exertion | |
100.10.100.50: Hand strength | |
100.10.100.60.10: Muscle biochemistry | |
100.10.100.60.20: Muscle components | |
100.10.100.60.30: Muscle functions | |
100.10.100.60.40: Muscle types | |
100.10.100.60: Muscle | |
100.10.100.70: Musculoskeletal anatomy | |
100.10.100.80: Robotics | |
100.10.100: Musculoskeletal system | |
100.10.10: Comparative anatomy | |
100.10.110.100: Peripheral nervous system | |
100.10.110.10: Central nervous system | |
100.10.110.110: Sensory physiology | |
100.10.110.120: Synapses | |
100.10.110.20: Ganglia | |
100.10.110.30: Motor systems | |
100.10.110.40: Nerve tissue | |
100.10.110.50: Nervous system components | |
100.10.110.60: Nervous system physiology | |
100.10.110.70: Neural homeostasis | |
100.10.110.80: Neural pathways | |
100.10.110.90: Neuroanatomy | |
100.10.110: Neurological system | |
100.10.120.10: Ocular anatomy | |
100.10.120: Ocular system | |
100.10.130: Physiogenomics | |
100.10.140.10: Aging | |
100.10.140.20: Biomineralization | |
100.10.140.30: Chronobiology | |
100.10.140.40: Energy metabolism | |
100.10.140.50: Homeostasis | |
100.10.140.60: Sleep | |
100.10.140: Physiological processes | |
100.10.150.10: Drug excretion | |
100.10.150.20: Renal anatomy | |
100.10.150.30: Renal circulation | |
100.10.150.40: Renal physiology | |
100.10.150: Renal system | |
100.10.160.10: Genital anatomy | |
100.10.160.20: Reproductive physiology | |
100.10.160.30: Sexual reproduction | |
100.10.160: Reproductive system | |
100.10.170.10: Respiratory physiology | |
100.10.170: Respiratory system | |
100.10.180: Sensory systems | |
100.10.190.10: Skin anatomy | |
100.10.190.20: Skin physiology | |
100.10.190: Skin | |
100.10.20.10: Cardiovascular anatomy | |
100.10.20.20: Circulatory physiology | |
100.10.20: Cardiovascular system | |
100.10.30: Cell physiology | |
100.10.40.10: Digestive anatomy | |
100.10.40.20.10: Digestive functions | |
100.10.40.20.20: Digestive regulation | |
100.10.40.20.30: Drug excretion | |
100.10.40.20: Digestive physiology | |
100.10.40: Digestive system | |
100.10.50: Electrophysiology | |
100.10.60.10: Adrenal cortex | |
100.10.60.20: Diabetic endocrinology | |
100.10.60.30.100: Hormone synthesis | |
100.10.60.30.10: Adrenarche | |
100.10.60.30.110: Hormone transport | |
100.10.60.30.120: Insulin | |
100.10.60.30.130: Insulin-like growth factor | |
100.10.60.30.140: Neuroendocrinology | |
100.10.60.30.150: Oxytocin | |
100.10.60.30.160: Paracrine mechanisms | |
100.10.60.30.170: Parathyroid | |
100.10.60.30.180: Pheromones | |
100.10.60.30.190: Pituitary | |
100.10.60.30.200: Prohormones | |
100.10.60.30.20: Autocrine mechanism | |
100.10.60.30.210: Reproductive endocrinology | |
100.10.60.30.220: Thyroid | |
100.10.60.30.30: Endocrine cells | |
100.10.60.30.40: Endocrine glands | |
100.10.60.30.50: Endocrine subsystems | |
100.10.60.30.60: Endocrine-related substances | |
100.10.60.30.70: Epidermal growth factor | |
100.10.60.30.80: Growth factors | |
100.10.60.30.90: Hormones | |
100.10.60.30: Endocrine physiology | |
100.10.60: Endocrine system | |
100.10.70: Fluid physiology | |
100.10.80.10: Antibodies | |
100.10.80.20: Antigens | |
100.10.80.30: Bone marrow | |
100.10.80.40: Cell surface molecules | |
100.10.80.50: Immune cells | |
100.10.80.60: Complement system | |
100.10.80.70: Cytokines | |
100.10.80.80: Lymphatic system | |
100.10.80: Immune physiology | |
100.10.90: Integrative physiology | |
100.100.10.10: Clinical chemistry | |
100.100.10.20: Clinical immunology | |
100.100.10.30: Transfusion medicine | |
100.100.10: Clinical laboratory sciences | |
100.100.20.10: Electroencephalography | |
100.100.20.20: Electromyography | |
100.100.20.30: Evoked potential | |
100.100.20.40: Nerve conduction study | |
100.100.20.50: Polysomnography | |
100.100.20: Clinical neurophysiology | |
100.100.30.10.10: Autopsy pathology | |
100.100.30.10.20: Cytopathology | |
100.100.30.10.30: Forensic pathology | |
100.100.30.10.40: Histopathology | |
100.100.30.10.50: Neuropathology | |
100.100.30.10.60: Surgical pathology | |
100.100.30.10: Anatomical pathology | |
100.100.30.20.10: Clinical chemistry | |
100.100.30.20.20: Clinical microbiology | |
100.100.30.20.30: Hematopathology | |
100.100.30.20.40: Molecular genetics | |
100.100.30.20: Clinical pathology | |
100.100.30.30.10: Biomarkers | |
100.100.30.30.20: Molecular pathology | |
100.100.30.30: General pathology | |
100.100.30: Pathology | |
100.100.40: Test evaluation | |
100.100: Diagnostic medicine | |
100.10: Anatomy and physiology | |
100.110.100: Medical devices | |
100.110.10: Adverse reactions | |
100.110.110: Neuropharmacology | |
100.110.120: Pharmacodynamics | |
100.110.130: Pharmacoeconomics | |
100.110.140: Pharmacoepidemiology | |
100.110.150: Pharmacogenetics | |
100.110.160.10: Drug absorption | |
100.110.160.20: Drug distribution | |
100.110.160.30: Drug excretion | |
100.110.160.40: Drug liberation | |
100.110.160.50: Drug metabolism | |
100.110.160: Pharmacokinetics | |
100.110.170: Psychopharmacology | |
100.110.180: Theoretical pharmacology | |
100.110.20.10: Drug dependence | |
100.110.20.20: Recreational drug use | |
100.110.20: Behavioral pharmacology | |
100.110.30: Cardiovascular pharmacology | |
100.110.40: Clinical pharmacology | |
100.110.50: Drug information | |
100.110.60: Drug interactions | |
100.110.70.10: Drug discovery | |
100.110.70.20: Drug licensing and regulation | |
100.110.70.30: Drug marketing | |
100.110.70: Drug research and development | |
100.110.80: Environmental pharmacology | |
100.110.90: Ethnopharmacology | |
100.110: Drugs and devices | |
100.120.10: Adrenal cortex | |
100.120.20.10: Diabetes mellitus type 1 | |
100.120.20.20: Diabetes mellitus type 2 | |
100.120.20.30: Gestational diabetes | |
100.120.20.40: Insulin | |
100.120.20: Diabetic endocrinology | |
100.120.30.100: Hormone synthesis | |
100.120.30.10: Adrenarche | |
100.120.30.110: Hormone transport | |
100.120.30.120: Insulin | |
100.120.30.130: Insulin-like growth factor | |
100.120.30.140: Neuroendocrinology | |
100.120.30.150: Oxytocin | |
100.120.30.160: Paracrine mechanisms | |
100.120.30.170: Parathyroid | |
100.120.30.180: Pheromones | |
100.120.30.190: Pituitary | |
100.120.30.200: Prohormones | |
100.120.30.20: Autocrine mechanism | |
100.120.30.210: Reproductive endocrinology | |
100.120.30.220: Thyroid | |
100.120.30.30: Endocrine cells | |
100.120.30.40: Endocrine glands | |
100.120.30.50: Endocrine subsystems | |
100.120.30.60: Endocrine-related substances | |
100.120.30.70: Epidermal growth factor | |
100.120.30.80: Growth factors | |
100.120.30.90: Hormones | |
100.120.30: Endocrine physiology | |
100.120.40: Neuroendocrinology | |
100.120.50: Pediatric endocrinology | |
100.120.60: Pituitary | |
100.120.70: Reproductive endocrinology | |
100.120.80.10: Graves' disease | |
100.120.80.20: Hashimoto disease | |
100.120.80.30: Hypothyroidism | |
100.120.80: Thyroid | |
100.120: Endocrinology | |
100.130.100: Epidemiology of aging | |
100.130.10: Biomarker epidemiology | |
100.130.110: Disease mapping | |
100.130.120: Genetic epidemiology | |
100.130.130: Infectious disease epidemiology | |
100.130.140: Lifecourse epidemiology | |
100.130.150: Molecular epidemiology | |
100.130.160: Pediatric epidemiology | |
100.130.170: Pharmacoepidemiology | |
100.130.180: Social epidemiology | |
100.130.190: Spatial epidemiology | |
100.130.200: Survey methods | |
100.130.20: Cancer epidemiology | |
100.130.30: Cardiovascular disease epidemiology | |
100.130.40: Clinical epidemiology | |
100.130.50: Conflict epidemiology | |
100.130.60: Disease informatics | |
100.130.70: Economic epidemiology | |
100.130.80: Environmental epidemiology | |
100.130.90: Epidemiological methods | |
100.130: Epidemiology | |
100.140.10.10: Hemorrhoids | |
100.140.100: Gastrointestinal infections | |
100.140.10: Anal and rectal disorders | |
100.140.110: Gastrointestinal motility disorders | |
100.140.120.10: Crohn disease | |
100.140.120.20: Ulcerative colitis | |
100.140.120: Inflammatory bowel disease | |
100.140.130.100: Wilson disease | |
100.140.130.10: Acute liver failure | |
100.140.130.20: Alcoholic liver disease | |
100.140.130.30: Autoimmune hepatitis | |
100.140.130.40: Cirrhosis | |
100.140.130.50: Hemochromatosis | |
100.140.130.60.10: Hepatitis A | |
100.140.130.60.20: Hepatitis B | |
100.140.130.60.30: Hepatitis C | |
100.140.130.60.40: Other viral hepatitis | |
100.140.130.60: Infectious hepatitis | |
100.140.130.70: Liver disease and pregnancy | |
100.140.130.80: Nonalcoholic steatohepatitis | |
100.140.130.90: Portal hypertension | |
100.140.130: Liver diseases | |
100.140.140.10: Pancreatitis | |
100.140.140: Pancreas | |
100.140.150.10: Hirschsprung disease | |
100.140.150: Pediatric gastroenterology | |
100.140.160: Small intestine | |
100.140.170.10: Gastritis | |
100.140.170.20: Peptic ulcer disease | |
100.140.170.30: Zollinger-Ellison syndrome | |
100.140.170: Stomach and duodenum | |
100.140.20: Appendicitis | |
100.140.30: Bacterial and foodborne illness | |
100.140.40.10: Cholecystitis and biliary colic | |
100.140.40.20: Cholelithiasis | |
100.140.40.30: Primary biliary cirrhosis | |
100.140.40.40: Primary sclerosing cholangitis | |
100.140.40: Biliary disorders | |
100.140.50: Celiac disease | |
100.140.60.10: Colon anatomy and development | |
100.140.60.20: Colonoscopy | |
100.140.60.30: Diverticulitis | |
100.140.60.40: Fistulas | |
100.140.60.50: Malrotation | |
100.140.60.60: Small bowel and colonic intussusception | |
100.140.60.70: Volvulus | |
100.140.60: Colon | |
100.140.70: Endoscopy | |
100.140.80: Esophagus | |
100.140.90: Gastrointestinal cancers | |
100.140: Gastroenterology and hepatology | |
100.150.10: Long-term care | |
100.150.20: Rehabilitation | |
100.150: Geriatrics | |
100.160: Global health | |
100.170.10.10.10: Autoimmune hemolytic anemia | |
100.170.10.10.20: Drug-induced hemolytic anemia | |
100.170.10.10.30: Glucose-6-phosphate dehydrogenase | |
100.170.10.10.30: Glucose-6-phosphate dehydrogenase deficiency | |
100.170.10.10: Hemolytic anemia | |
100.170.10.20: Iron deficiency anemia | |
100.170.10.30.10: Folate deficiency | |
100.170.10.30.20: Vitamin B12 deficiency | |
100.170.10.30: Megaloblastic anemia | |
100.170.100.10: Hypergammaglobulinemia | |
100.170.100.20: Multiple myeloma | |
100.170.100: Plasma cell disorders | |
100.170.10: Anemia | |
100.170.110.10: Disseminated intravascular coagulation | |
100.170.110.20: Thrombocytopenia | |
100.170.110.30: Wiskott-Aldrich syndrome | |
100.170.110: Platelets | |
100.170.120: Red cells | |
100.170.130: Transfusion medicine | |
100.170.140.10: Neuropenia | |
100.170.140: White cells | |
100.170.20.10: Aplastic anemia | |
100.170.20: Bone marrow failure | |
100.170.30: Bone marrow and stem cell transplantation | |
100.170.40.10: Antiphospholipid syndrome | |
100.170.40.20: Coagulation factor deficiences | |
100.170.40.30: Disseminated intravascular coagulation | |
100.170.40.40: Factor V Leiden | |
100.170.40.50: Hemophilia A | |
100.170.40.60: Hemophilia B | |
100.170.40.70: Protein C deficiency | |
100.170.40.80: Protein S deficiency | |
100.170.40.90: von Willebrand disease | |
100.170.40: Coagulation disorders | |
100.170.50.10.10: Acute lymphoblastic leukemia | |
100.170.50.10.20: Acute myeloid leukemia | |
100.170.50.10.30: Chronic lymphoblastic leukemia | |
100.170.50.10.40: Chronic myeloid leukemia | |
100.170.50.10: Leukemias | |
100.170.50.20.10: Hodgkin lymphoma | |
100.170.50.20.20: Non-Hodgkin lymphoma | |
100.170.50.20: Lymphomas | |
100.170.50.30: Myelodysplastic syndromes | |
100.170.50.40: Myelomas and lymphoproliferative diseases | |
100.170.50.50.10: Chronic myeloid leukemia | |
100.170.50.50.20: Leukocytosis | |
100.170.50.50.30: Polycythemia vera | |
100.170.50.50.40: Thrombocytosis | |
100.170.50.50: Myeloproliferative disorders | |
100.170.50: Hematologic cancers and related disorders | |
100.170.60: Hematopoiesis | |
100.170.70: Heme synthesis | |
100.170.80.10: Sickle cell disease | |
100.170.80.20: Alpha-thalassemia | |
100.170.80.30: Beta-thalassemia | |
100.170.80: Hemoglobinopathies | |
100.170.90: Pediatric hematology | |
100.170: Hematology | |
100.180.10.1000: Mycobacterium | |
100.180.10.100: Bacillus cereus infection | |
100.180.10.1010: Mycobacterium avium complex | |
100.180.10.1020: Mycoplasma pneumonia | |
100.180.10.1030: Nanobacterium | |
100.180.10.1040: Necrotizing fasciitis | |
100.180.10.1050: Nocardiosis | |
100.180.10.1060: Nontuberculous mycobacteria | |
100.180.10.1070: Nosocomial infections | |
100.180.10.1080: Omphalitis | |
100.180.10.1090: Orbital cellulitis | |
100.180.10.10: Acinetobacter infections | |
100.180.10.1100: Osteomyelitis | |
100.180.10.110: Bacteremia | |
100.180.10.1110: Overwhelming post-splenectomy infections | |
100.180.10.1120: Panton-Valentine leukocidin | |
100.180.10.1130: Pasteurella multocida | |
100.180.10.1140: Pasteurellosis | |
100.180.10.1150: Pericoronal abscesses | |
100.180.10.1160: Perio-endo | |
100.180.10.1170: Periodontal abscesses | |
100.180.10.1180: Periorbital cellulitis | |
100.180.10.1190: Peritonsillar abscess | |
100.180.10.1200: Pertussis | |
100.180.10.120: Bacterial meningitis | |
100.180.10.1210: Phenol-soluble modulin | |
100.180.10.1220: Pinta | |
100.180.10.1230: Plagues | |
100.180.10.1240: Pneumococcus | |
100.180.10.1250: Pneumonic plagues | |
100.180.10.1260: Pott disease | |
100.180.10.1270: Prevotella infection | |
100.180.10.1280: Proctitis | |
100.180.10.1290: Proteus OX19 | |
100.180.10.1300: Pseudomonas infections | |
100.180.10.130: Bacterial pneumonia | |
100.180.10.1310: Psittacosis | |
100.180.10.1320: Pyemia | |
100.180.10.1330: Pyomyositis | |
100.180.10.1340: Q-fever | |
100.180.10.1350: Rat-bite fever | |
100.180.10.1360: Relapsing fever | |
100.180.10.1370: Rickettsia prowazekii | |
100.180.10.1380: Rickettsia rickettsii | |
100.180.10.1390: Rickettsia | |
100.180.10.1400: Rickettsialpox | |
100.180.10.140: Bacteroides infection | |
100.180.10.1410: Rocky Mountain spotted fever | |
100.180.10.1420: Salmonella | |
100.180.10.1430: Salmonellosis | |
100.180.10.1440: Scarlet fever | |
100.180.10.1450: Scrub typhus | |
100.180.10.1460: Septicemic plagues | |
100.180.10.1470: Serratia infections | |
100.180.10.1480: Shigellosis | |
100.180.10.1490: Shigellosis infections | |
100.180.10.1500: Smet | |
100.180.10.150: Bartonellosis | |
100.180.10.1510: Sodoku | |
100.180.10.1520: Soft-tissue infections | |
100.180.10.1530: Southern tick-associated rash illness | |
100.180.10.1540: Spondylitis | |
100.180.10.1550: Staph infections | |
100.180.10.1560: Staphylococcal food poisoning | |
100.180.10.1570: Staphylococcal infection | |
100.180.10.1580: Staphylococcal scalded skin syndrome | |
100.180.10.1590: Staphylococcus aureus | |
100.180.10.1600: Strep throat | |
100.180.10.160: Bejel | |
100.180.10.1610: Streptococcal pharyngitis | |
100.180.10.1620: Streptococcal infections | |
100.180.10.1630: Swimmer's ear | |
100.180.10.1640: Swine brucellosis | |
100.180.10.1650: Syphilitic aortitis | |
100.180.10.1660: Tetanus | |
100.180.10.1670: Toxic shock syndrome | |
100.180.10.1680: Toxic shock syndrome | |
100.180.10.1690: Trachoma | |
100.180.10.1700: Trench fever | |
100.180.10.170: Bloodstream infections | |
100.180.10.1710: Tropical ulcers | |
100.180.10.1720.10: Bovine tuberculosis in humans | |
100.180.10.1720.20: Extensively drug-resistant | |
100.180.10.1720.20: Extensively drug-resistant tuberculosis | |
100.180.10.1720.30: Miliary tuberculosis | |
100.180.10.1720.40: Multi-drug-resistant tuberculosis | |
100.180.10.1720: Tuberculosis | |
100.180.10.1730: Tularemia | |
100.180.10.1740: Typhus | |
100.180.10.1750: Ureaplasma urealyticum infections | |
100.180.10.1760: Urinary tract infections | |
100.180.10.1770: Vancomycin-resistant staphylococcus aureus | |
100.180.10.1780: Vibrio vulnificus | |
100.180.10.1790: Waterhouse-Friderichsen syndrome | |
100.180.10.1800: Widal test | |
100.180.10.180: Borrelia infection | |
100.180.10.1810: Yaws | |
100.180.10.1820: Yersinia pestis | |
100.180.10.1830: Yersinia pseudotuberculosis | |
100.180.10.1840: Yersinia pseudotuberculosis infection | |
100.180.10.1850: Yersiniosis | |
100.180.10.190: Botryomycosis | |
100.180.10.200: Botulism | |
100.180.10.20: Acinetobacter baumannii | |
100.180.10.210: Bovine tuberculosis in humans | |
100.180.10.220: Brazilian purpuric fever | |
100.180.10.230: Brodie abscess | |
100.180.10.240: Bubonic plague | |
100.180.10.250: Burkholderia cepacia complex | |
100.180.10.260: Burkholderia infection | |
100.180.10.270: Buruli ulcer | |
100.180.10.280: Campylobacter | |
100.180.10.290: Campylobacteriosis | |
100.180.10.300: Capnocytophaga canimorsus | |
100.180.10.30: Actinomycosis | |
100.180.10.310: Caries | |
100.180.10.320: Cariogram | |
100.180.10.330: Carrion's disease | |
100.180.10.340: Cellulitis | |
100.180.10.350: Centor criteria | |
100.180.10.360: Cholera | |
100.180.10.370: Chronic bacterial prostatitis | |
100.180.10.380: Chronic recurrent multifocal osteomyelitis | |
100.180.10.390: Clostridium difficile | |
100.180.10.400: Combined periodontal-endodontic abscesses | |
100.180.10.40: Acute prostatitis | |
100.180.10.410: Combined periodontal-endodontic lesions | |
100.180.10.420: Congenital syphilis | |
100.180.10.430: Contagious bovine pleuropneumonia | |
100.180.10.440: Copper-silver ionization | |
100.180.10.450: Diphtheria | |
100.180.10.460: Diphtheritic stomatitis | |
100.180.10.470: Ehrlichiosis | |
100.180.10.480: Ehrlichiosis (canine) | |
100.180.10.490: El Tor | |
100.180.10.500: Endo-perio | |
100.180.10.50: Aeromonas hydrophila | |
100.180.10.510: Enterobacter infections | |
100.180.10.520: Enterococcus infection | |
100.180.10.530: Epidemic typhus | |
100.180.10.540: Epiglottitis | |
100.180.10.550: Erysipelas | |
100.180.10.560: Escherichia coli | |
100.180.10.570: European Working Group for Legionella | |
100.180.10.570: European Working Group for Legionella Infections | |
100.180.10.580: Fitz-Hugh-Curtis syndrome | |
100.180.10.590: Food poisoning by Clostridium perfringens | |
100.180.10.600: Fusobacterium infections | |
100.180.10.60: Annual ryegrass toxicity | |
100.180.10.610: Garre's sclerosing osteomyelitis | |
100.180.10.620: Gas gangrene | |
100.180.10.630: Ghon complex | |
100.180.10.640: Gingival abscesses | |
100.180.10.650: Glanders | |
100.180.10.660: Granuloma inguinale | |
100.180.10.670: Group A streptococcal infection | |
100.180.10.680: Group B streptococcal infection | |
100.180.10.690: Haemophilus influenzae | |
100.180.10.700: Helicobacter pylori | |
100.180.10.70: Anthrax | |
100.180.10.710: Hansen disease | |
100.180.10.720: Hemolytic-uremic syndrome | |
100.180.10.730: History of tuberculosis | |
100.180.10.740: Hot-tub folliculitis | |
100.180.10.750: Human ewingii ehrlichiosis | |
100.180.10.760: Human granulocytic anaplasmosis | |
100.180.10.770: Human monocytic ehrlichiosis | |
100.180.10.780: Human monocytotropic ehrlichiosis | |
100.180.10.790: Impetigo | |
100.180.10.800: Kingella kingae infection | |
100.180.10.80: Antibiotic-associated colitis | |
100.180.10.810: Klebsiella infections | |
100.180.10.820: Klebsiella pneumonia | |
100.180.10.830: Lady Windermere syndrome | |
100.180.10.840: Legionella | |
100.180.10.850: Legionellosis | |
100.180.10.860: Lemierre syndrome | |
100.180.10.870: Leprosy | |
100.180.10.880: Leptospirosis | |
100.180.10.890: Listeriosis | |
100.180.10.900: Ludwig angina | |
100.180.10.90: Arcanobacterium haemolyticum infection | |
100.180.10.910: Lyme disease | |
100.180.10.920: Malignant external otitis | |
100.180.10.930: Melioidosis | |
100.180.10.940: Meningitis | |
100.180.10.950: Meningoccal septicemia | |
100.180.10.960: Meningococcal disease | |
100.180.10.970: Meningococcal infections | |
100.180.10.980: Methicillin-resistant Staphylococcus aureus | |
100.180.10.990: Murine typhus | |
100.180.100.10: Bovine spongiform encephalopathy | |
100.180.100.20: Creutzfeldt-Jakob disease | |
100.180.100.30: Fatal familial insomnia | |
100.180.100.40: Gerstmann-Straussler-Scheinker disease | |
100.180.100.50: Kuru | |
100.180.100: Prion diseases | |
100.180.10: Bacterial diseases | |
100.180.110.100: Molluscum contagiosum | |
100.180.110.10: AIDS | |
100.180.110.110: Scabies | |
100.180.110.120: Syphilis | |
100.180.110.130: Trichomoniasis | |
100.180.110.20: Bacterial vaginosis | |
100.180.110.30: Candidiasis | |
100.180.110.40: Chancroid | |
100.180.110.50: Chlamydia | |
100.180.110.60: Condyloma acuminata | |
100.180.110.70: Gonorrhea | |
100.180.110.80: Herpes simplex | |
100.180.110.90: Human papillomavirus infection | |
100.180.110: Sexually transmitted diseases | |
100.180.120: Skin infections | |
100.180.130.10: Filariasis | |
100.180.130.20: Flavivirus | |
100.180.130.30: Foodborne trematodiases | |
100.180.130.40.10: Plasmodium falciparum | |
100.180.130.40.20: Plasmodium malariae | |
100.180.130.40.30: Plasmodium ovale | |
100.180.130.40.40: Plasmodium vivax | |
100.180.130.40: Malaria | |
100.180.130.50: Neurocysticercosis | |
100.180.130.60: Strongyloidiasis | |
100.180.130.70: Treponematoses | |
100.180.130.80: Tuberculosis | |
100.180.130: Tropical diseases (non-neglected) | |
100.180.140: Travel-associated diseases | |
100.180.150: Urologic infections | |
100.180.160.100: Crimean-Congo hemorrhagic fever | |
100.180.160.10: Argentine hemorrhagic fever | |
100.180.160.110: Cytomegalovirus infection | |
100.180.160.120: Dengue | |
100.180.160.130: Ebola hemorrhagic fever | |
100.180.160.140: Encephalitis lethargica | |
100.180.160.150: Enterovirus infection | |
100.180.160.160: Epstein-Barr virus infectious mononucleosis | |
100.180.160.170: Erythema infectiosum | |
100.180.160.180: Exanthem subitum | |
100.180.160.190: Hand, foot, and mouth disease | |
100.180.160.200: Hantavirus pulmonary syndrome | |
100.180.160.20: Astrovirus infection | |
100.180.160.210: Hemorrhagic fever with renal syndrome | |
100.180.160.220.10: Hepatitis A | |
100.180.160.220.20: Hepatitis B | |
100.180.160.220.30: Hepatitis C | |
100.180.160.220.40: Hepatitis delta | |
100.180.160.220.50: Hepatitis E | |
100.180.160.220: Hepatitis | |
100.180.160.230: Herpes simplex | |
100.180.160.240.10: HIV clinical manifestations | |
100.180.160.240.20: HIV diagnosis and management | |
100.180.160.240.30: HIV epidemiology | |
100.180.160.240.40: HIV opportunistic infections | |
100.180.160.240.50: HIV prevention | |
100.180.160.240.60: Retrovirology and HIV | |
100.180.160.240.60: Retrovirology and HIV immunopathogenesis | |
100.180.160.240: HIV | |
100.180.160.250: Human bocavirus infection | |
100.180.160.260: Human metapneumovirus infection | |
100.180.160.270: Human papillomavirus infection | |
100.180.160.280: Human parainfluenza virus infection | |
100.180.160.290: Influenza | |
100.180.160.300: Japanese encephalitis | |
100.180.160.30: Bk virus infection | |
100.180.160.310: Jungle yellow fever | |
100.180.160.320: Lassa fever | |
100.180.160.330: Lymphocytic choriomeningitis | |
100.180.160.340: Marburg hemorrhagic fever | |
100.180.160.350: Measles | |
100.180.160.360: Mumps | |
100.180.160.370: Poliomyelitis | |
100.180.160.380: Progressive multifocal leukoencephalopathy | |
100.180.160.390: Rabies | |
100.180.160.400: Respiratory syncytial virus infection | |
100.180.160.40: Bolivian hemorrhagic fever | |
100.180.160.410: Rhinovirus infection | |
100.180.160.420: Rift Valley fever | |
100.180.160.430: Rotavirus infection | |
100.180.160.440: Rubella | |
100.180.160.450: SARS | |
100.180.160.460: Shingles | |
100.180.160.470: Smallpox | |
100.180.160.480: Venezuelan equine encephalitis | |
100.180.160.490: Venezuelan hemorrhagic fever | |
100.180.160.500: Viral hemorrhagic fevers | |
100.180.160.50: Brazilian hemorrhagic fever | |
100.180.160.510: Viral pneumonia | |
100.180.160.520: West Nile fever | |
100.180.160.530: Yellow fever | |
100.180.160.60: Calicivirus infection | |
100.180.160.70: Chickenpox | |
100.180.160.80: Colorado tick fever | |
100.180.160.90: Common cold | |
100.180.160: Viral diseases | |
100.180.170.10: Anopheles | |
100.180.170.20: Lice | |
100.180.170.30: Mosquitoes | |
100.180.170.40: Ticks | |
100.180.170.50: Triatoma | |
100.180.170.60: Tsetse fly | |
100.180.170: Vectors and hosts | |
100.180.180.100: Escherichia coli | |
100.180.180.10: Avian influenza A viruses | |
100.180.180.110: Hantavirus | |
100.180.180.120: Hendra virus | |
100.180.180.130: Henipavirus | |
100.180.180.140: Korean hemorrhagic fever | |
100.180.180.150: Kyasanur Forest disease | |
100.180.180.160: Lymphocytic choriomeningitis virus | |
100.180.180.170: L?brea fever | |
100.180.180.180: Marburg fever | |
100.180.180.190: Mediterranean spotted fever | |
100.180.180.200: Monkey B | |
100.180.180.20: Barmah Forest virus | |
100.180.180.210: Nipah fever | |
100.180.180.220: Ocular karva migrans | |
100.180.180.230: Omsk hemorrhagic fever | |
100.180.180.240: Orf (disease) | |
100.180.180.250: Oropouche fever | |
100.180.180.260: Puumala virus | |
100.180.180.270: Streptococcus suis | |
100.180.180.280: Taeniasis | |
100.180.180.30: Borna virus infection | |
100.180.180.40: Bovine tuberculosis | |
100.180.180.50: Brucellosis | |
100.180.180.60: Cat scratch disease | |
100.180.180.70: Chlamydophila psittaci | |
100.180.180.80: Cowpox | |
100.180.180.90: Ebola | |
100.180.180: Zoonoses | |
100.180.20.100: Histoplasmosis | |
100.180.20.10: Aspergillosis | |
100.180.20.110: Microsporidiosis | |
100.180.20.120: Mycetoma | |
100.180.20.130: Mycosis | |
100.180.20.140: Mycosis infections | |
100.180.20.150: Paracoccidiomycosis | |
100.180.20.160: Pneumocystis | |
100.180.20.170: Rhinosporidiosis | |
100.180.20.180: Sporotrichosis | |
100.180.20.190: Subcutaneous mycoses | |
100.180.20.200: Superficial mycoses | |
100.180.20.20: Black piedra | |
100.180.20.210: Systemic mycoses | |
100.180.20.220: Tinea | |
100.180.20.230: White piedra | |
100.180.20.240: Zygomycosis | |
100.180.20.30: Blastomycosis | |
100.180.20.40: Chromoblastomycosis | |
100.180.20.50: Coccidioidomycosis | |
100.180.20.60: Cryptococcosis | |
100.180.20.70: Cutaneous mycoses | |
100.180.20.80: Dermatophytosis | |
100.180.20.90: Geotrichosis | |
100.180.20: Fungal diseases | |
100.180.30: Gastrointestinal infections | |
100.180.40: Gynecologic infections | |
100.180.50: Infectious disease control | |
100.180.60: Infectious disease modeling | |
100.180.70: Infectious diseases of the nervous system | |
100.180.80.100: Buruli ulcer | |
100.180.80.10: African trypanosomiasis | |
100.180.80.110: Chagas disease | |
100.180.80.120: Cholera | |
100.180.80.130: Clonorchiasis | |
100.180.80.140: Cysticercosis | |
100.180.80.150: Dengue fever | |
100.180.80.160: Dracunculiasis | |
100.180.80.170: Echinococcosis | |
100.180.80.180: Ectoparasitic infections | |
100.180.80.190: Fascioliasis | |
100.180.80.200: Fasciolopsiasis | |
100.180.80.20: Amebiasis | |
100.180.80.210: Food-borne trematodes | |
100.180.80.220: Giardiasis | |
100.180.80.230: Hookworm | |
100.180.80.240: Japanese encephalitis | |
100.180.80.250: Jungle yellow fever | |
100.180.80.260: Leishmaniasis | |
100.180.80.270: Leprosy | |
100.180.80.280: Leptospirosis | |
100.180.80.290: Loiasis | |
100.180.80.300: Lymphatic filariasis | |
100.180.80.30: Arboviral infections | |
100.180.80.310: Mycetoma | |
100.180.80.320: Myiasis | |
100.180.80.330: Neurocysticercosis | |
100.180.80.340: Nutritional diseases | |
100.180.80.350: Onchocerciasis | |
100.180.80.360: Opisthorchiasis | |
100.180.80.370: Paracoccidiomycosis | |
100.180.80.380: Paragonimiasis | |
100.180.80.390: Pinta | |
100.180.80.400: Rabies | |
100.180.80.40: Ascariasis | |
100.180.80.410: Rift Valley fever | |
100.180.80.420: Scabies | |
100.180.80.430: Schistosomiasis | |
100.180.80.440: Soil-transmitted helminths | |
100.180.80.450: Strongyloidiasis | |
100.180.80.460: Syphilis | |
100.180.80.470: Toxocariasis | |
100.180.80.480: Toxoplasmosis | |
100.180.80.490: Trachoma | |
100.180.80.500: Trichuriasis | |
100.180.80.50: Balantidiasis | |
100.180.80.510: Viral hemorrhagic fevers | |
100.180.80.520: Yaws | |
100.180.80.60: Bartonella | |
100.180.80.70: Bejel | |
100.180.80.80: Bovine tuberculosis in humans | |
100.180.80.90: Brucellosis | |
100.180.80: Neglected tropical diseases | |
100.180.90.100: Cryptosporidiosis | |
100.180.90.10: African trypanosomiasis | |
100.180.90.110: Cutaneous larva migrans | |
100.180.90.120: Cyclosporiasis | |
100.180.90.130: Cysticercosis | |
100.180.90.140: Dientamoebiasis | |
100.180.90.150: Diphyllobothriasis | |
100.180.90.160: Dracunculiasis | |
100.180.90.170: Echinococcosis | |
100.180.90.180: Ectoparasitic infections | |
100.180.90.190: Elephantiasis | |
100.180.90.200: Enterobiasis | |
100.180.90.20: Amebiasis | |
100.180.90.210: Fasciolopsiasis | |
100.180.90.220: Fasciolosis | |
100.180.90.230: Filariasis | |
100.180.90.240: Free-living amebic infection | |
100.180.90.250: Giardiasis | |
100.180.90.260: Gnathostomiasis | |
100.180.90.270: Helminth infection | |
100.180.90.280: Hookworm infection | |
100.180.90.290: Hookworm | |
100.180.90.300: Hymenolepiasis | |
100.180.90.30: Ascariasis | |
100.180.90.310: Isosporiasis | |
100.180.90.320: Katayama fever | |
100.180.90.330: Leishmaniasis | |
100.180.90.340: Loiasis | |
100.180.90.350: Lymphatic filariasis | |
100.180.90.360.10: Plasmodium falciparum | |
100.180.90.360.20: Plasmodium malariae | |
100.180.90.360.30: Plasmodium ovale | |
100.180.90.360.40: Plasmodium vivax | |
100.180.90.360: Malaria | |
100.180.90.370: Metagonimiasis | |
100.180.90.380: Microsporidiosis | |
100.180.90.390: Myiasis | |
100.180.90.400: Onchocerciasis | |
100.180.90.40: Babesiosis | |
100.180.90.410: Opisthorchiasis | |
100.180.90.420: Paragonimiasis | |
100.180.90.430: Parasitic intestinal diseases | |
100.180.90.440: Pediculosis | |
100.180.90.450: Primary amoebic meningoencephalitis | |
100.180.90.460: Protozoan infections | |
100.180.90.470: Rhinosporidiosis | |
100.180.90.480: Scabies | |
100.180.90.490: Schistosomiasis | |
100.180.90.500: Soil-transmitted helminths | |
100.180.90.50: Balantidiasis | |
100.180.90.510: Strongyloidiasis | |
100.180.90.520: Taeniasis | |
100.180.90.530: Toxocariasis | |
100.180.90.540: Toxoplasmosis | |
100.180.90.550: Trichinellosis | |
100.180.90.560: Trichinosis | |
100.180.90.570: Trichuriasis | |
100.180.90.60: Baylisascaris infection | |
100.180.90.70: Blastocystis hominis infection | |
100.180.90.80: Chagas disease | |
100.180.90.90: Clonorchiasis | |
100.180.90: Parasitic diseases | |
100.180: Infectious diseases | |
100.190: Mental health | |
100.20.100: Perioperative hemostasis | |
100.20.10: Anesthesiology monitoring | |
100.20.110: Regional anesthesia | |
100.20.20: Anesthesiology technology | |
100.20.30: Anesthetic mechanisms | |
100.20.40: General anesthesia | |
100.20.50: Neurosurgical care | |
100.20.60: Obstetric anesthesiology | |
100.20.70: Pain management | |
100.20.80: Pediatric anesthesiology | |
100.20.90: Perioperative critical care | |
100.200: Metabolic disorders | |
100.20: Anesthesiology | |
100.210: Nephrology | |
100.220: Neurology | |
100.230: Non-clinical medicine | |
100.240: Nursing science | |
100.250: Nutrition | |
100.260: Obstetrics and gynecology | |
100.270: Oncology | |
100.280: Ophthalmology | |
100.290: Oral medicine | |
100.30.100: Congenital heart disease | |
100.30.10: Acute cardiovascular problems | |
100.30.110: Coronary artery disease | |
100.30.120: Electrophysiology | |
100.30.130: Geriatric cardiology | |
100.30.140: Heart failure | |
100.30.150: Hemodynamics | |
100.30.160: Hypertension | |
100.30.170: Interventional cardiology | |
100.30.180: Myocardial infarction | |
100.30.190: Pacing | |
100.30.200: Pediatric cardiology | |
100.30.20: Angina | |
100.30.210: Pericardial diseases | |
100.30.220: Peripheral vascular diseases | |
100.30.230: Pulmonary vascular diseases | |
100.30.240: Stroke | |
100.30.250: Valvular disease | |
100.30.260: Vascular biology | |
100.30.270: Venous thromboembolism | |
100.30.30: Aortic diseases | |
100.30.40: Arrhythmias | |
100.30.50: Atherosclerosis | |
100.30.60: Cardiomyopathies | |
100.30.70: Cardiovascular diseases in women | |
100.30.80: Cardiovascular imaging | |
100.30.90: Cardiovascular pharmacology | |
100.300: Otorhinolaryngology | |
100.30: Cardiovascular | |
100.310: Palliative care | |
100.320: Pediatrics | |
100.330: Physiotherapy and rehabilitation | |
100.340: Primary care | |
100.350: Public health | |
100.360: Pulmonology | |
100.370: Radiology | |
100.380: Rheumatology | |
100.390: Sports and exercise medicine | |
100.40.10.10: Familial hypercholesterolemia | |
100.40.10.20: Hereditary nonpolyposis colorectal cancer | |
100.40.10.30: Huntington disease | |
100.40.10.40: Marfan syndrome | |
100.40.10.50: Neurofibromatosis type 1 | |
100.40.10.60: Polycystic kidney disease | |
100.40.100: Personalized medicine | |
100.40.10: Autosomal dominant | |
100.40.110.10: Duchenne muscular dystrophy | |
100.40.110.20: Hemophilia | |
100.40.110.30: Lesch-Nyhan syndrome | |
100.40.110.40: Rett syndrome | |
100.40.110: X-linked | |
100.40.120: Y-linked | |
100.40.20.100: Roberts syndrome | |
100.40.20.10: Alpha-thalassemia | |
100.40.20.110: Sickle cell disease | |
100.40.20.120: Spinal muscular atrophy | |
100.40.20.130: Tay-Sachs disease | |
100.40.20.140: Wilson disease | |
100.40.20.20: Beta-thalassemia | |
100.40.20.30: Cystic fibrosis | |
100.40.20.40: Galactosemia | |
100.40.20.50: Gaucher disease | |
100.40.20.60: Glycogen storage diseases | |
100.40.20.70: Mucopolysaccharidoses | |
100.40.20.80: Niemann-Pick disease | |
100.40.20.90: Phenylketonuria | |
100.40.20: Autosomal recessive | |
100.40.30.10: Aneuploidy | |
100.40.30.20: Chromosomal deletions and duplications | |
100.40.30.30: Down syndrome | |
100.40.30.40: Translocations | |
100.40.30.50: Turner syndrome | |
100.40.30: Chromosomal disorders | |
100.40.40: Congenital hereditary myopathies | |
100.40.50.10: Angelman syndrome | |
100.40.50.20: Beckwith-Wiedemann syndrome | |
100.40.50.30: Prader-Willi syndrome | |
100.40.50: Disorders of imprinting | |
100.40.60: Gene therapy | |
100.40.70: Genetic counseling | |
100.40.80: Genetic testing | |
100.40.90.10: Diabetes mellitus and deafness | |
100.40.90.20: Encephalomyopathy | |
100.40.90.30: Lactic acidosis | |
100.40.90.40: Leber hereditary optic neuropathy | |
100.40.90.50: Leigh syndrome | |
100.40.90.60: Mitochondrial myopathy | |
100.40.90.70: Myoclonic epilepsy with ragged red fibers | |
100.40.90.80: Myoneurogenic gastrointestinal encephalopathy | |
100.40.90: Mitochondrial diseases | |
100.400: Surgery | |
100.40: Clinical genetics | |
100.410: Toxicology | |
100.420: Urology | |
100.430: Women's health | |
100.50.100.10: Neuroimmunology | |
100.50.100.20: Pulmonary immunology | |
100.50.100.30: Reproductive immunology | |
100.50.100.40: Transplantation | |
100.50.100.50: Tumor immunology | |
100.50.100: Immunologic subspecialties | |
100.50.10: Allergy and hypersensitivity | |
100.50.110.10: Immunoassays | |
100.50.110.20: Immunofluorescence | |
100.50.110.30: Immunohistochemical analysis | |
100.50.110: Immunologic techniques | |
100.50.120: Immunomodulation | |
100.50.130: Immunopathology | |
100.50.140: Major histocompatibility complex | |
100.50.20: Antigen processing and recognition | |
100.50.30.100: Mixed connective tissue disease | |
100.50.30.10: Ankylosing spondylitis | |
100.50.30.110: Multiple sclerosis | |
100.50.30.120: Myasthenia gravis | |
100.50.30.130: Pemphigus vulgaris | |
100.50.30.140: Pernicious anemia | |
100.50.30.150: Polymyositis | |
100.50.30.160: Primary biliary cirrhosis | |
100.50.30.170: Psoriasis | |
100.50.30.180: Rheumatoid arthritis | |
100.50.30.190: Scleroderma | |
100.50.30.200: Sjogren syndrome | |
100.50.30.20: Crohn disease | |
100.50.30.210: Temporal arteritis | |
100.50.30.220: Vasculitis | |
100.50.30.230: Vitiligo | |
100.50.30.240: Wegener granulomatosis | |
100.50.30.30: Dermatomyositis | |
100.50.30.40: Diabetes mellitus type 1 | |
100.50.30.50: Graves' disease | |
100.50.30.60: Hashimoto disease | |
100.50.30.70: Idiopathic thrombocytopenic purpura | |
100.50.30.80: Kawasaki disease | |
100.50.30.90: Lupus erythematosus | |
100.50.30: Autoimmune diseases | |
100.50.40: Genetics of the immune system | |
100.50.50.10: Antibody-producing cells | |
100.50.50.20: Antigen-presenting cells | |
100.50.50.30: B cells | |
100.50.50.40: NK cells | |
100.50.50.50: Monocytes | |
100.50.50.60: T cells | |
100.50.50: Immune cells | |
100.50.60: Immune response | |
100.50.70.10: Bone marrow | |
100.50.70.20: Complement system | |
100.50.70.30: Cytokines | |
100.50.70.40: Lymphoid organs | |
100.50.70: Immune system | |
100.50.80.100: Immunity to infections | |
100.50.80.10: Adaptive immunity | |
100.50.80.110: Immunizations | |
100.50.80.120: Immunoregulation | |
100.50.80.130: Immunotherapy | |
100.50.80.140: Inflammation | |
100.50.80.150: Innate immunity | |
100.50.80.20: Aging and immunity | |
100.50.80.30: Humoral immunity | |
100.50.80.40: Immune activation | |
100.50.80.50: Immune defense | |
100.50.80.60: Immune deficiency | |
100.50.80.70: Immune privilege | |
100.50.80.80: Immune suppression | |
100.50.80.90: Immune tolerance | |
100.50.80: Immunity | |
100.50.90: Immunoglobulins | |
100.50: Clinical immunology | |
100.60.100: Observational studies | |
100.60.10: Animal models of disease | |
100.60.110: Preclinical models | |
100.60.120: Prospective studies | |
100.60.130: Qualitative studies | |
100.60.140: Reporting guidelines | |
100.60.150: Retrospective studies | |
100.60.160: Statistical methods | |
100.60.170: Survey research | |
100.60.180: Systematic reviews | |
100.60.20.10: Phase I | |
100.60.20.20: Phase II | |
100.60.20.30: Phase III | |
100.60.20.40: Phase IV | |
100.60.20: Clinical trials | |
100.60.30: Case-control studies | |
100.60.40: Cohort studies | |
100.60.50: Cross-sectional studies | |
100.60.60: Epidemiology | |
100.60.70: Longitudinal studies | |
100.60.80: Meta-analyses | |
100.60.90: Modeling | |
100.60: Clinical research design | |
100.70: Complementary and alternative medicine | |
100.80.100: Renal critical care | |
100.80.10: Acute cardiovascular problems | |
100.80.110: Respiratory failure | |
100.80.120: Resuscitation | |
100.80.130: Sepsis | |
100.80.140: Toxicology | |
100.80.150: Ventilatory support | |
100.80.20: Acute renal failure | |
100.80.30: Critical care team organization | |
100.80.40: Fluid management | |
100.80.50: Gastrointestinal critical care | |
100.80.60: Multiple organ failure | |
100.80.70: Neurointensive care | |
100.80.80: Pediatric critical care | |
100.80.90: Perioperative critical care | |
100.80: Critical care and emergency medicine | |
100.90.100: Hair and nail diseases | |
100.90.10: Atopic dermatitis | |
100.90.110: Inflammatory diseases | |
100.90.120: Pediatric dermatology | |
100.90.130: Photodermatology and skin aging | |
100.90.140: Pigmentary disorders | |
100.90.150: Skin infections | |
100.90.160.10: Benign skin neoplasms | |
100.90.160.20.10: Basal cell carcinomas | |
100.90.160.20.20: Melanomas | |
100.90.160.20.30: Squamous cell carcinomas | |
100.90.160.20: Malignant skin neoplasms | |
100.90.160: Skin neoplasms | |
100.90.170: Urticaria | |
100.90.20: Acne-like disorders | |
100.90.30: Bullous disorders | |
100.90.40: Burn management | |
100.90.50: Contact dermatitis | |
100.90.60: Connective tissue diseases | |
100.90.70: Dermatologic pathology | |
100.90.80: Dermatologic and cosmetic surgery | |
100.90.90: Drug eruptions | |
100.90: Dermatology | |
100: Medicine | |
10: Agriculture | |
110: Physics | |
120: Science policy | |
130: Social and behavioral sciences | |
140: Veterinary science | |
20.30.40.100: X-ray astronomy | |
20.30.40.60: Optical astronomy | |
20.30.40.70: Radar astronomy | |
20.30.40.80: Radio astronomy | |
20.30.40.90: Ultraviolet astronomy | |
20.30.40: Observational astronomy | |
20.30.50: Spherical astronomy | |
20.30: Astronomy | |
20.40.100: Doppler effects | |
20.40.10: Astronomical spectroscopy | |
20.40.110: Galaxies | |
20.40.120: Gamma-ray bursts | |
20.40.130: Gravitational waves | |
20.40.140: Interstellar medium | |
20.40.150: Mass accretion | |
20.40.160: Matter-density power spectrum | |
20.40.170: Microwave background | |
20.40.180: Nebulae | |
20.40.190: Nucleosynthesis | |
20.40.200: Neutron stars | |
20.40.20: Astroparticle physics | |
20.40.210: Polarized electromagnetic radiation | |
20.40.220: Pulsars | |
20.40.230: Quark matter | |
20.40.240: Redshift | |
20.40.250.10: Solar flares | |
20.40.250.20: Sunspots | |
20.40.250: Solar physics | |
20.40.260: Space plasmas | |
20.40.270: Standard candles | |
20.40.280: Stellar physics | |
20.40.290: Supernovae | |
20.40.30: Black holes | |
20.40.40: Celestial mechanics | |
20.40.50: Computational astrophysics | |
20.40.60: Cosmic rays | |
20.40.70: Cosmochemistry | |
20.40.80: Dark energy | |
20.40.90: Dark matter | |
20.40: Astrophysics | |
20.50.10: Expanding universe | |
20.50.20: Flat universe | |
20.50.30: Missing mass | |
20.50.40: Origin of the universe | |
20.50: Cosmology | |
20.60.100.10: Atmospheric tides | |
20.60.100.20: Earth tides | |
20.60.100.30: Ocean tides | |
20.60.100.40: Tidal forces | |
20.60.100: Tides | |
20.60.10: Asteroids | |
20.60.20: Comets | |
20.60.30: Dwarf planets | |
20.60.40: Extrasolar planets | |
20.60.50: Interplanetary magnetic field | |
20.60.60: Meteors | |
20.60.70: Planet formation | |
20.60.80.100: Sun | |
20.60.80.10: Dwarf planets | |
20.60.80.110: Uranus | |
20.60.80.120: Venus | |
20.60.80.20: Jupiter | |
20.60.80.30: Mars | |
20.60.80.40: Mercury (planet) | |
20.60.80.50: Natural satellites | |
20.60.80.60: Neptune | |
20.60.80.70: Phobos | |
20.60.80.80: Pluto | |
20.60.80.90: Saturn | |
20.60.80: Planets | |
20.60.90: Solar system | |
20.60: Planetary sciences | |
20.70.100: Space missions | |
20.70.10: Life support (space travel) | |
20.70.110: Space station | |
20.70.120: Space tourism | |
20.70.130.10: Intergalactic spaceflight | |
20.70.130.20: Interplanetary spaceflight | |
20.70.130.30: Interstellar spaceflight | |
20.70.130.40: Reusable launch systems | |
20.70.130.50: Spacecraft | |
20.70.130.60: Spacecraft propulsion | |
20.70.130.70: Weightlessness | |
20.70.130: Spaceflight | |
20.70.140: Spaceports | |
20.70.150: Spacesuits | |
20.70.160: Targets of exploration | |
20.70.20: Lunar exploration | |
20.70.30: Mars Exploration Program | |
20.70.40: Militarization of space | |
20.70.50: Physical exploration | |
20.70.60: Satellites | |
20.70.70: Space advocacy | |
20.70.80: Space agencies | |
20.70.90: Space colonization | |
20.70: Space exploration | |
20: Astronomical sciences | |
30.10.100.10.10: Biological fluid mechanics | |
30.10.100.10.20: Bone and joint mechanics | |
30.10.100.10.30: Cell mechanics | |
30.10.100.10.40: Flight mechanics | |
30.10.100.10.50: Tissue mechanics | |
30.10.100.10: Biomechanics | |
30.10.100.20: Bone | |
30.10.100.30: Cartilage | |
30.10.100.40: Exertion | |
30.10.100.50: Hand strength | |
30.10.100.60.10: Muscle biochemistry | |
30.10.100.60.20: Muscle components | |
30.10.100.60.30: Muscle functions | |
30.10.100.60.40: Muscle types | |
30.10.100.60: Muscle | |
30.10.100.70: Musculoskeletal anatomy | |
30.10.100.80: Robotics | |
30.10.100: Musculoskeletal system | |
30.10.10: Comparative anatomy | |
30.10.110.100: Peripheral nervous system | |
30.10.110.10: Central nervous system | |
30.10.110.110: Sensory physiology | |
30.10.110.120: Synapses | |
30.10.110.20: Ganglia | |
30.10.110.30: Motor systems | |
30.10.110.40: Nerve tissue | |
30.10.110.50: Nervous system components | |
30.10.110.60: Nervous system physiology | |
30.10.110.70: Neural homeostasis | |
30.10.110.80: Neural pathways | |
30.10.110.90: Neuroanatomy | |
30.10.110: Neurological system | |
30.10.120.10: Ocular anatomy | |
30.10.120: Ocular system | |
30.10.130: Physiogenomics | |
30.10.140.10: Aging | |
30.10.140.20: Biomineralization | |
30.10.140.30: Chronobiology | |
30.10.140.40: Energy metabolism | |
30.10.140.50: Homeostasis | |
30.10.140.60: Sleep | |
30.10.140: Physiological processes | |
30.10.150.10: Drug excretion | |
30.10.150.20: Renal anatomy | |
30.10.150.30: Renal circulation | |
30.10.150.40: Renal physiology | |
30.10.150: Renal system | |
30.10.160.10: Genital anatomy | |
30.10.160.20: Reproductive physiology | |
30.10.160.30: Sexual reproduction | |
30.10.160: Reproductive system | |
30.10.170.10: Respiratory physiology | |
30.10.170: Respiratory system | |
30.10.180.10: Skin anatomy | |
30.10.180.20: Skin physiology | |
30.10.180: Skin | |
30.10.20.10: Cardiovascular anatomy | |
30.10.20.20: Circulatory physiology | |
30.10.20: Cardiovascular system | |
30.10.30: Cell physiology | |
30.10.40.10: Digestive anatomy | |
30.10.40.20.10: Digestive functions | |
30.10.40.20.20: Digestive regulation | |
30.10.40.20.30: Drug excretion | |
30.10.40.20: Digestive physiology | |
30.10.40: Digestive system | |
30.10.50: Electrophysiology | |
30.10.60.10: Adrenal cortex | |
30.10.60.20: Diabetic endocrinology | |
30.10.60.30.100: Hormone synthesis | |
30.10.60.30.10: Adrenarche | |
30.10.60.30.110: Hormone transport | |
30.10.60.30.120: Insulin | |
30.10.60.30.130: Insulin-like growth factor | |
30.10.60.30.140: Neuroendocrinology | |
30.10.60.30.150: Oxytocin | |
30.10.60.30.160: Paracrine mechanisms | |
30.10.60.30.170: Parathyroid | |
30.10.60.30.180: Pheromones | |
30.10.60.30.190: Pituitary | |
30.10.60.30.200: Prohormones | |
30.10.60.30.20: Autocrine mechanism | |
30.10.60.30.210: Reproductive endocrinology | |
30.10.60.30.220: Thyroid | |
30.10.60.30.30: Endocrine cells | |
30.10.60.30.40: Endocrine glands | |
30.10.60.30.50: Endocrine subsystems | |
30.10.60.30.60: Endocrine-related substances | |
30.10.60.30.70: Epidermal growth factor | |
30.10.60.30.80: Growth factors | |
30.10.60.30.90: Hormones | |
30.10.60.30: Endocrine physiology | |
30.10.60: Endocrine system | |
30.10.70: Fluid physiology | |
30.10.80.10: Bone marrow | |
30.10.80.20: Immune cells | |
30.10.80.30: Complement system | |
30.10.80.40: Cytokines | |
30.10.80.50: Lymphatic system | |
30.10.80: Immune physiology | |
30.10.90: Integrative physiology | |
30.100.10.10: Agro-population ecology | |
30.100.10.20: Agronomic ecology | |
30.100.10.30: Ecological political economy | |
30.100.10.40: Ecosystems agroecology | |
30.100.10.50: Holon agroecology | |
30.100.100: Coastal ecology | |
30.100.10: Agroecology | |
30.100.110.10: Community assembly | |
30.100.110.20: Community structure | |
30.100.110.30: Ecological remediation | |
30.100.110.40: Ecological risk | |
30.100.110.50: Energy flow | |
30.100.110.60: Food web structure | |
30.100.110.70: Niche construction | |
30.100.110.80: Species interactions | |
30.100.110.90: Trophic interactions | |
30.100.110: Community ecology | |
30.100.120: Conservation science | |
30.100.130: Ecological economics | |
30.100.140.10: Aquatic environments | |
30.100.140.20: Freshwater environments | |
30.100.140.30: Marine environments | |
30.100.140.40: Terrestrial environments | |
30.100.140: Ecological environments | |
30.100.150.100: Population growth | |
30.100.150.10: Biomass (ecology) | |
30.100.150.110: Population size | |
30.100.150.120: Productivity (ecology) | |
30.100.150.130: Q10 temperature coefficient | |
30.100.150.140: Relative abundance distribution | |
30.100.150.150: Species diversity | |
30.100.150.160: Species richness | |
30.100.150.20: Carrying capacity | |
30.100.150.30: Ecological yield | |
30.100.150.40: Effective population size | |
30.100.150.50: Extinction risk | |
30.100.150.60: Maximum sustainable yield | |
30.100.150.70: Minimum viable population | |
30.100.150.80: Optimum sustainable yield | |
30.100.150.90: Photosynthetic efficiency | |
30.100.150: Ecological metrics | |
30.100.160: Ecophysiology | |
30.100.170.10: Artificial ecosystems | |
30.100.170.20: Ecosystem engineering | |
30.100.170.30: Ecosystem functioning | |
30.100.170.40: Ecosystem modeling | |
30.100.170: Ecosystems | |
30.100.180: Environmental protection | |
30.100.190: Evolutionary ecology | |
30.100.200: Freshwater ecology | |
30.100.20: Autecology | |
30.100.210: Global change ecology | |
30.100.220: Industrial ecology | |
30.100.230: Limnetic ecology | |
30.100.240: Macroecology | |
30.100.250.10: Coral reefs | |
30.100.250: Marine ecology | |
30.100.260: Microbial ecology | |
30.100.270: Paleoecology | |
30.100.280: Physiological ecology | |
30.100.290.10: Plant-environment interactions | |
30.100.290: Plant ecology | |
30.100.300: Population ecology | |
30.100.30: Behavioral ecology | |
30.100.310: Restoration ecology | |
30.100.320: Soil ecology | |
30.100.330: Spatial and landscape ecology | |
30.100.340: Species extinction | |
30.100.350: Systems ecology | |
30.100.360: Theoretical ecology | |
30.100.370: Terrestrial ecology | |
30.100.380: Urban ecology | |
30.100.40: Biodiversity | |
30.100.50: Bioindicators | |
30.100.60: Biota | |
30.100.70: Biogeochemistry | |
30.100.80: Biogeography | |
30.100.90: Chemical ecology | |
30.100: Ecology | |
30.10: Anatomy and physiology | |
30.110.100.10: Cladistics | |
30.110.100.20: Molecular systematics | |
30.110.100.30: Phyletic patterns | |
30.110.100.40: Phylocode | |
30.110.100.50: Phylogenetics | |
30.110.100.60.10: Animal taxonomy | |
30.110.100.60.20: Microbial taxonomy | |
30.110.100.60.30: Plant taxonomy | |
30.110.100.60: Taxonomy | |
30.110.100: Evolutionary systematics | |
30.110.10: Aging | |
30.110.110: Evolutionary theory | |
30.110.120.10: Coevolution | |
30.110.120.20: Concerted evolution | |
30.110.120.30: Convergent evolution | |
30.110.120.40: Directed evolution | |
30.110.120.50: Divergent evolution | |
30.110.120.60: Microevolution | |
30.110.120.70: Macroevolution | |
30.110.120.80: Parallel evolution | |
30.110.120.90: Phenetic evolution | |
30.110.120: Forms of evolution | |
30.110.130: Genomic evolution | |
30.110.140.10: Animal evolution | |
30.110.140.20: Eukaryotic evolution | |
30.110.140.30: Human evolution | |
30.110.140.40: Microbial evolution | |
30.110.140.50: Plant evolution | |
30.110.140: Organismal evolution | |
30.110.150: Origin of life | |
30.110.160.10: Biostratigraphy | |
30.110.160.20: Invertebrate paleontology | |
30.110.160.30: Micropaleontology | |
30.110.160.40: Paleobiology | |
30.110.160.50: Paleobotany | |
30.110.160.60: Paleoclimatology | |
30.110.160.70: Paleoecology | |
30.110.160.80: Taphonomy | |
30.110.160.90: Vertebrate paleontology | |
30.110.160: Paleontology | |
30.110.170.100: Ploidy | |
30.110.170.10: Effective population size | |
30.110.170.20: Gene flow | |
30.110.170.30: Gene pool | |
30.110.170.40: Genetic drift | |
30.110.170.50: Genetic polymorphism | |
30.110.170.60: Haplotypes | |
30.110.170.70: Mutation | |
30.110.170.80: Natural selection | |
30.110.170.90: Neutral theory | |
30.110.170: Population genetics | |
30.110.20: Animal behavior | |
30.110.30: Behavioral ecology | |
30.110.40: Comparative genomics | |
30.110.50: Evolutionary developmental biology | |
30.110.60: Evolutionary ecology | |
30.110.70: Evolutionary genetics | |
30.110.80: Evolutionary immunology | |
30.110.90.100: Sexual selection | |
30.110.90.10: Adaptation | |
30.110.90.110: Sexual conflict | |
30.110.90.120: Speciation | |
30.110.90.130: Species extinction | |
30.110.90.20: Coevolution | |
30.110.90.30: Emergence | |
30.110.90.40: Evolutionary selection | |
30.110.90.50: Genetic drift | |
30.110.90.60: Hybridization | |
30.110.90.70: Introgression | |
30.110.90.80: Mutation | |
30.110.90.90: Natural selection | |
30.110.90: Evolutionary processes | |
30.110: Evolutionary biology | |
30.120.100.10: Mutagenesis | |
30.120.100.20: Mutation types | |
30.120.100.30: Mutational hypotheses | |
30.120.100: Genetic mutation | |
30.120.10: Animal genetics | |
30.120.110: Genetic screens | |
30.120.120: Genetics of disease | |
30.120.130: Genome-wide association studies | |
30.120.140.100: Linkage (genetics) | |
30.120.140.10: Chromosomal inheritance | |
30.120.140.110: Phenotypes | |
30.120.140.120: Quantitative traits | |
30.120.140.130: Trait locus | |
30.120.140.20: Complex traits | |
30.120.140.30: Epistasis | |
30.120.140.40: Gene flow | |
30.120.140.50: Genetic determinism | |
30.120.140.60: Genetic suppression | |
30.120.140.70: Genotypes | |
30.120.140.80: Haploinsufficiency | |
30.120.140.90: Heterosis | |
30.120.140: Heredity | |
30.120.150.10.10: Familial hypercholesterolemia | |
30.120.150.10.20: Hereditary nonpolyposis colorectal | |
30.120.150.10.20: Hereditary nonpolyposis colorectal cancer | |
30.120.150.10.30: Huntington disease | |
30.120.150.10.40: Marfan syndrome | |
30.120.150.10.50: Neurofibromatosis type 1 | |
30.120.150.10.60: Polycystic kidney disease | |
30.120.150.100: Genome-wide association studies | |
30.120.150.10: Autosomal dominant | |
30.120.150.110.10: Diabetes mellitus and deafness | |
30.120.150.110.20: Encephalomyopathy | |
30.120.150.110.30: Lactic acidosis | |
30.120.150.110.40: Leber hereditary optic neuropathy | |
30.120.150.110.50: Leigh syndrome | |
30.120.150.110.60: Mitochondrial myopathy | |
30.120.150.110.70: Myoclonic epilepsy with ragged red | |
30.120.150.110.70: Myoclonic epilepsy with ragged red fibers | |
30.120.150.110.80: Myoneurogenic gastrointestinal | |
30.120.150.110.80: Myoneurogenic gastrointestinal encephalopathy | |
30.120.150.110: Mitochondrial diseases | |
30.120.150.120: Personalized medicine | |
30.120.150.130.10: Duchenne muscular dystrophy | |
30.120.150.130.20: Hemophilia | |
30.120.150.130.30: Lesch-Nyhan syndrome | |
30.120.150.130.40: Rett syndrome | |
30.120.150.130: X-linked | |
30.120.150.140: Y-linked | |
30.120.150.20.100: Roberts syndrome | |
30.120.150.20.10: Alpha-thalassemia | |
30.120.150.20.110: Sickle cell disease | |
30.120.150.20.120: Spinal muscular atrophy | |
30.120.150.20.130: Tay-Sachs disease | |
30.120.150.20.140: Wilson disease | |
30.120.150.20.20: Beta-thalassemia | |
30.120.150.20.30: Cystic fibrosis | |
30.120.150.20.40: Galactosemia | |
30.120.150.20.50: Gaucher disease | |
30.120.150.20.60: Glycogen storage diseases | |
30.120.150.20.70: Mucopolysaccharidoses | |
30.120.150.20.80: Niemann-Pick disease | |
30.120.150.20.90: Phenylketonuria | |
30.120.150.20: Autosomal recessive | |
30.120.150.30.10: Aneuploidy | |
30.120.150.30.20: Chromosomal deletions and duplications | |
30.120.150.30.30: Down syndrome | |
30.120.150.30.40: Translocations | |
30.120.150.30.50: Turner syndrome | |
30.120.150.30: Chromosomal disorders | |
30.120.150.40: Congenital hereditary myopathies | |
30.120.150.50.10: Angelman syndrome | |
30.120.150.50.20: Beckwith-Wiedemann syndrome | |
30.120.150.50.30: Prader-Willi syndrome | |
30.120.150.50: Disorders of imprinting | |
30.120.150.60: Gene therapy | |
30.120.150.70: Genetic association studies | |
30.120.150.80: Genetic counseling | |
30.120.150.90: Genetic testing | |
30.120.150: Human genetics | |
30.120.160.10: Gene classes | |
30.120.160.20: Gene duplication | |
30.120.160.30: Gene identification and analysis | |
30.120.160.40: Gene regulation | |
30.120.160: Molecular genetics | |
30.120.170.10: Crop genetics | |
30.120.170: Plant genetics | |
30.120.180.100: Ploidy | |
30.120.180.10: Effective population size | |
30.120.180.20: Gene flow | |
30.120.180.30: Gene pool | |
30.120.180.40: Genetic drift | |
30.120.180.50: Genetic polymorphism | |
30.120.180.60: Haplotypes | |
30.120.180.70: Mutation | |
30.120.180.80: Natural selection | |
30.120.180.90: Neutral theory | |
30.120.180: Population genetics | |
30.120.20: Cancer genetics | |
30.120.30.10: Human cloning | |
30.120.30.20: Organismal cloning | |
30.120.30.30: Reproductive cloning | |
30.120.30.40: Therapeutic cloning | |
30.120.30: Cloning | |
30.120.40.10: Cytogenetic analysis | |
30.120.40.20: Cytogenetic techniques | |
30.120.40.30: Cytological landmarks | |
30.120.40: Cytogenetics | |
30.120.50.10: DNA modification | |
30.120.50.20: Genomic imprinting | |
30.120.50.30: Histone modification | |
30.120.50.40: Chromatin | |
30.120.50.50: RNA interference | |
30.120.50.60: X chromosome inactivation | |
30.120.50: Epigenetics | |
30.120.60.10: DNA modification | |
30.120.60.20: DNA transcription | |
30.120.60.30: Histone modification | |
30.120.60.40: Chromatin | |
30.120.60.50: Protein translation | |
30.120.60.60: RNA interference | |
30.120.60.70: RNA processing | |
30.120.60.80: RNA stability | |
30.120.60.90: RNA transport | |
30.120.60: Gene expression | |
30.120.70: Gene function | |
30.120.80: Gene networks | |
30.120.90: Gene splicing | |
30.120: Genetics | |
30.130.10.10: Centromeres | |
30.130.10.20: Chromatin | |
30.130.10.30: Chromosome structure and function | |
30.130.10.40: Meiosis | |
30.130.10.50: Mitosis | |
30.130.10.60: Telomeres | |
30.130.10.70: X chromosome inactivation | |
30.130.100.10: Gene therapy | |
30.130.100.20: Genetic counseling | |
30.130.100.30: Genetic testing | |
30.130.100.40: Pharmacogenomics | |
30.130.100: Genomic medicine | |
30.130.10: Chromosome biology | |
30.130.110: Metagenomics | |
30.130.120: Pharmacogenomics | |
30.130.130: Physiogenomics | |
30.130.140: Structural genomics | |
30.130.20: Comparative genomics | |
30.130.30: Functional genomics | |
30.130.40.100: Spacer regions | |
30.130.40.10: Gene ontologies | |
30.130.40.110: Trait locus analysis | |
30.130.40.120: Transcriptomes | |
30.130.40.20: Gene prediction | |
30.130.40.30: Genetic maps | |
30.130.40.40: Genetic networks | |
30.130.40.50: Genetic screens | |
30.130.40.60: Genome scans | |
30.130.40.70: Genome-wide association studies | |
30.130.40.80: Linkage maps | |
30.130.40.90: Sequence assembly tools | |
30.130.40: Genome analysis tools | |
30.130.50: Genome complexity | |
30.130.60.10: Mutation databases | |
30.130.60.20: Sequence databases | |
30.130.60: Genome databases | |
30.130.70: Genome evolution | |
30.130.80: Genome expression analysis | |
30.130.90: Genome sequencing | |
30.130: Genomics | |
30.140: Histology | |
30.150.100.10: Neuroimmunology | |
30.150.100.20: Pulmonary immunology | |
30.150.100.30: Reproductive immunology | |
30.150.100.40: Transplantation | |
30.150.100.50: Tumor immunology | |
30.150.100: Immunologic subspecialties | |
30.150.10: Allergy and hypersensitivity | |
30.150.110.10: Immunoassays | |
30.150.110.20: Immunofluorescence | |
30.150.110.30: Immunohistochemical analysis | |
30.150.110: Immunologic techniques | |
30.150.120: Immunomodulation | |
30.150.130: Immunopathology | |
30.150.140: Major histocompatibility complex | |
30.150.20: Antigen processing and recognition | |
30.150.30: Autoimmunity | |
30.150.40: Genetics of the immune system | |
30.150.50.10: Antibody-producing cells | |
30.150.50.20: Antigen-presenting cells | |
30.150.50.30: B cells | |
30.150.50.40: NK cells | |
30.150.50.50: Monocytes | |
30.150.50.60: T cells | |
30.150.50: Immune cells | |
30.150.60: Immune response | |
30.150.70.10: Bone marrow | |
30.150.70.20: Complement system | |
30.150.70.30: Cytokines | |
30.150.70.40: Lymphoid organs | |
30.150.70: Immune system | |
30.150.80.100: Immunity to infections | |
30.150.80.10: Adaptive immunity | |
30.150.80.110: Immunizations | |
30.150.80.120: Immunoregulation | |
30.150.80.130: Immunotherapy | |
30.150.80.140: Inflammation | |
30.150.80.150: Innate immunity | |
30.150.80.20: Aging and immunity | |
30.150.80.30: Humoral immunity | |
30.150.80.40: Immune activation | |
30.150.80.50: Immune defense | |
30.150.80.60: Immune deficiency | |
30.150.80.70: Immune privilege | |
30.150.80.80: Immune suppression | |
30.150.80.90: Immune tolerance | |
30.150.80: Immunity | |
30.150.90: Immunoglobulins | |
30.150: Immunology | |
30.160.10: Coastal ecology | |
30.160.20: Corals | |
30.160.30: Fisheries science | |
30.160.40: Freshwater ecology | |
30.160.50: Marine conservation | |
30.160.60: Marine ecology | |
30.160.70: Marine monitoring | |
30.160.80: Marine technology | |
30.160.90: Phycology | |
30.160: Marine biology | |
30.170.100: Microbial control | |
30.170.10: Applied microbiology | |
30.170.110: Microbial ecology | |
30.170.120: Microbial evolution | |
30.170.130: Microbial growth and development | |
30.170.140: Microbial metabolism | |
30.170.150: Microbial mutation | |
30.170.160: Microbial pathogens | |
30.170.170: Microbial physiology | |
30.170.180.10: Fungal biochemistry | |
30.170.180.20: Fungal classification | |
30.170.180.30: Fungal evolution | |
30.170.180.40: Fungal physiology | |
30.170.180.50: Fungal reproduction | |
30.170.180.60: Fungal structure | |
30.170.180.70: Fungi | |
30.170.180.80: Spores | |
30.170.180.90: Yeast | |
30.170.180: Mycology | |
30.170.190.10: Parasite evolution | |
30.170.190.20: Parasite physiology | |
30.170.190.30: Parasite groups | |
30.170.190.40: Quantitative parasitology | |
30.170.190: Parasitology | |
30.170.20.10: Archaeal biochemistry | |
30.170.20.20: Archaeal taxonomy | |
30.170.20.30: Archaeal evolution | |
30.170.20.40: Archaeal physiology | |
30.170.200: Pathogenesis | |
30.170.20: Archaeans | |
30.170.210: Plant microbiology | |
30.170.220.10.10: Balantidium coli | |
30.170.220.10.20: Entamoeba histolytica | |
30.170.220.10.30: Giardia lamblia | |
30.170.220.10.40: Leishmania | |
30.170.220.10.50: Plasmodium falciparum | |
30.170.220.10.60: Toxoplasma gondii | |
30.170.220.10.70: Trypanosoma | |
30.170.220.10: Parastic protozoans | |
30.170.220.20: Protozoan classification | |
30.170.220: Protozoology | |
30.170.230.10: Acrasiomycota | |
30.170.230.20: Dictyosteliomycota | |
30.170.230.30: Myxomycota | |
30.170.230.40: Plasmodiophoromycota | |
30.170.230: Slime molds | |
30.170.240.10: Anopheles | |
30.170.240.20: Lice | |
30.170.240.30: Mosquitoes | |
30.170.240.40: Ticks | |
30.170.240.50: Triatoma | |
30.170.240.60: Tsetse fly | |
30.170.240.70: Viral vectors | |
30.170.240: Vector biology | |
30.170.250.100: Viral evolution | |
30.170.250.10: Animal models of infection | |
30.170.250.110: Viral immune evasion | |
30.170.250.120: Viral persistence and latency | |
30.170.250.130.10: Ambisense coding | |
30.170.250.130.20: Immediate-early promoter | |
30.170.250.130.30: Internal ribosome entry site | |
30.170.250.130.40: Late expression factor | |
30.170.250.130.50: Viral latency | |
30.170.250.130.60: Viral nucleic acid | |
30.170.250.130: Viral replication | |
30.170.250.20: Antivirals | |
30.170.250.30: Co-infections | |
30.170.250.40: Emerging viral diseases | |
30.170.250.50: Immunodeficiency viruses | |
30.170.250.60: Mechanisms of resistance and susceptibility | |
30.170.250.70.10: DNA viruses | |
30.170.250.70.20: Other viral groupings | |
30.170.250.70.30: Retroviruses | |
30.170.250.70.40: RNA viruses | |
30.170.250.70.50: Viral genera unassigned to a family | |
30.170.250.70: Viral classification | |
30.170.250.80: Viral disease diagnosis | |
30.170.250.90: Viral enzymes | |
30.170.250: Virology | |
30.170.30.10: Escherichia coli | |
30.170.30.20: Gram positive | |
30.170.30.30: Gram negative | |
30.170.30.40: Salmonella | |
30.170.30.50: Staphylococci | |
30.170.30.60: Streptococci | |
30.170.30: Bacterial pathogens | |
30.170.40.10: Bacterial biochemistry | |
30.170.40.20: Bacterial biofilms | |
30.170.40.30: Bacterial taxonomy | |
30.170.40.40: Bacterial evolution | |
30.170.40.50: Bacterial physiology | |
30.170.40: Bacteriology | |
30.170.50: Emerging infectious diseases | |
30.170.60: Host-pathogen interaction | |
30.170.70.100: Immunotherapy | |
30.170.70.10: Adaptive immunity | |
30.170.70.110: Inflammation | |
30.170.70.120: Innate immunity | |
30.170.70.20: Aging and immunity | |
30.170.70.30: Humoral immunity | |
30.170.70.40: Immune activation | |
30.170.70.50: Immune defense | |
30.170.70.60: Immune privilege | |
30.170.70.70: Immune tolerance | |
30.170.70.80: Immunizations | |
30.170.70.90: Immunoregulation | |
30.170.70: Immunity | |
30.170.80: Industrial microbiology | |
30.170.90: Medical microbiology | |
30.170: Microbiology | |
30.20.10: Extraterrestrial life | |
30.20.20: Extremophiles | |
30.20.30: Organic environments | |
30.20: Astrobiology | |
30.30.100.10.10: Membrane characteristics | |
30.30.100.10.20: Membrane composition | |
30.30.100.10.30: Membrane metabolism | |
30.30.100.10.40: Membrane proteins | |
30.30.100.10.50: Membrane structures | |
30.30.100.10: Cell membrane | |
30.30.100.20: Energy-producing processes | |
30.30.100.30.10: Basement membrane | |
30.30.100.30.20: Connective tissue | |
30.30.100.30.30: Extracellular matrix adhesions | |
30.30.100.30.40: Extracellular matrix composition | |
30.30.100.30.50: Integrins | |
30.30.100.30: Extracellular matrix | |
30.30.100.40: Histochemistry | |
30.30.100.50: Immunocytochemistry | |
30.30.100.60: In situ hybridization | |
30.30.100.70: Organelles | |
30.30.100: Cytochemistry | |
30.30.10: Biocatalysis | |
30.30.110: Drug discovery | |
30.30.120.10: Coenzyme | |
30.30.120.20.100: Isozymes | |
30.30.120.20.10: Adenylate cyclase | |
30.30.120.20.110: Ketoacid lyases | |
30.30.120.20.120: Ligases | |
30.30.120.20.130: Luciferase | |
30.30.120.20.140: Lyases | |
30.30.120.20.150: Mucolytic enzymes | |
30.30.120.20.160: Nuclease | |
30.30.120.20.170: Oxidoreductases | |
30.30.120.20.180: Pepsins | |
30.30.120.20.190: Phosphorylases | |
30.30.120.20.200: Saccharidases | |
30.30.120.20.20: Collagenase | |
30.30.120.20.210: Transferases | |
30.30.120.20.30: Dehydrogenases | |
30.30.120.20.40: Dextransucrase | |
30.30.120.20.50: Esterases | |
30.30.120.20.60: Glucanases | |
30.30.120.20.70: Glycosyltransferases | |
30.30.120.20.80: Hydrolases | |
30.30.120.20.90: Isomerases | |
30.30.120.20: Enzyme classes | |
30.30.120.30: Enzyme kinetics | |
30.30.120.40: Enzyme metabolism | |
30.30.120.50: Enzyme precursors | |
30.30.120.60: Enzyme regulation | |
30.30.120.70: Enzyme structure | |
30.30.120: Enzymes | |
30.30.130.10: Carbohydrates | |
30.30.130.20: Glycolipids | |
30.30.130.30: Glycoproteins | |
30.30.130.40: Polysaccharides | |
30.30.130.50: Proteoglycans | |
30.30.130: Glycobiology | |
30.30.140: Hormones | |
30.30.150: Immunochemistry | |
30.30.160.100: Lipid structure | |
30.30.160.10: Fats | |
30.30.160.110: Neutral lipids | |
30.30.160.120: Oils | |
30.30.160.130: Sphingolipids | |
30.30.160.140: Sterols | |
30.30.160.150: Waxes | |
30.30.160.20: Fatty acids | |
30.30.160.30: Fatty alcohols | |
30.30.160.40: Glycerides | |
30.30.160.50: Isoprenoids | |
30.30.160.60: Lipid aggregates | |
30.30.160.70: Lipid classes | |
30.30.160.80: Lipid mediators | |
30.30.160.90: Lipid metabolism | |
30.30.160: Lipids | |
30.30.170: Macromolecular assemblies | |
30.30.180.100: Protein metabolism | |
30.30.180.10: Biological transport | |
30.30.180.110: Tissue distribution | |
30.30.180.20: Biorecognition | |
30.30.180.30: Biosynthesis | |
30.30.180.40: Bone and mineral metabolism | |
30.30.180.50: Carbohydrate metabolism | |
30.30.180.60: Lipid metabolism | |
30.30.180.70: Metabolic pathways | |
30.30.180.80: Nitrogen metabolism | |
30.30.180.90: Oxygen metabolism | |
30.30.180: Metabolism | |
30.30.190.10.100: Nitric oxide | |
30.30.190.10.10: Acetylcholine | |
30.30.190.10.110: Oxytocin | |
30.30.190.10.120: Serotonin | |
30.30.190.10.20: Dopamine | |
30.30.190.10.30: Eicosanoids | |
30.30.190.10.40: Endocannabinoids | |
30.30.190.10.50: Gamma-aminobutyric acid | |
30.30.190.10.60: Glutamate | |
30.30.190.10.70: Nerve growth factor | |
30.30.190.10.80: Neuropeptides | |
30.30.190.10.90: Neurotransmitters | |
30.30.190.10: Neurochemicals | |
30.30.190.20: Neuroendocrinology | |
30.30.190.30: Neurogenesis | |
30.30.190.40: Neuromodulation | |
30.30.190.50: Synaptic plasticity | |
30.30.190: Neurochemistry | |
30.30.200.10.100: Forms of DNA | |
30.30.200.10.10: Complementary DNA | |
30.30.200.10.20: DNA amplification | |
30.30.200.10.30: DNA metabolism | |
30.30.200.10.40: DNA modification | |
30.30.200.10.50: DNA recombination | |
30.30.200.10.60: DNA repair | |
30.30.200.10.70: DNA replication | |
30.30.200.10.80: DNA structure | |
30.30.200.10.90: DNA synthesis | |
30.30.200.10: DNA | |
30.30.200.20: Nucleic acid components | |
30.30.200.30: Nucleotides | |
30.30.200.40.10: RNA interference | |
30.30.200.40.20: RNA processing | |
30.30.200.40.30: RNA stability | |
30.30.200.40.40: RNA structure | |
30.30.200.40.50: RNA synthesis | |
30.30.200.40.60: RNA transport | |
30.30.200.40: RNA | |
30.30.200.50: Ribozymes | |
30.30.200.60: Synthetic nucleic acids | |
30.30.200: Nucleic acids | |
30.30.20: Biochemistry simulations | |
30.30.210.10: Carbohydrate biosynthesis | |
30.30.210.20: Energy production | |
30.30.210.30: Photosynthesis | |
30.30.210.40: Secondary metabolism | |
30.30.210: Plant biochemistry | |
30.30.220.100: Cytoskeletal proteins | |
30.30.220.10: Acetylcholine receptors | |
30.30.220.110: DNA-binding proteins | |
30.30.220.120: Defense proteins | |
30.30.220.130: Extracellular matrix proteins | |
30.30.220.140: Globular proteins | |
30.30.220.150: Globulins | |
30.30.220.160: Growth factors | |
30.30.220.170: Hemoproteins | |
30.30.220.180: Immune system proteins | |
30.30.220.190: Intracellular receptors | |
30.30.220.200: Ion channels | |
30.30.220.20: Acute phase proteins | |
30.30.220.210.10: Apolipoprotein genes | |
30.30.220.210.20: Apolipoproteins | |
30.30.220.210.30: Lipoprotein metabolism | |
30.30.220.210.40: Lipoprotein receptors | |
30.30.220.210.50: Lipoprotein secretion | |
30.30.220.210.60: Lipoprotein structure | |
30.30.220.210.70: Proteolipids | |
30.30.220.210: Lipoproteins | |
30.30.220.220: Luminescent proteins | |
30.30.220.230: Major histocompatibility antigens | |
30.30.220.240: Muscarinic acetylcholine receptors | |
30.30.220.250: Nicotinic acetylcholine receptors | |
30.30.220.260: Nutrient and storage proteins | |
30.30.220.270: Organismal proteins | |
30.30.220.280: Plasma proteins | |
30.30.220.290: Protein chemistry | |
30.30.220.300: Protein classes | |
30.30.220.30: Antiport proteins | |
30.30.220.310: Protein interactions | |
30.30.220.320: Protein structure | |
30.30.220.330: Protein synthesis | |
30.30.220.340: Proteome | |
30.30.220.350: Recombinant proteins | |
30.30.220.360: Regulatory proteins | |
30.30.220.370: Serum amyloid p component | |
30.30.220.380: Structural proteins | |
30.30.220.390: Synport proteins | |
30.30.220.400: T-cell receptors | |
30.30.220.40: C-reactive proteins | |
30.30.220.410: Tissue proteins | |
30.30.220.420: Transmembrane proteins | |
30.30.220.430: Transmembrane transport proteins | |
30.30.220.50: Chaperone proteins | |
30.30.220.60: Chromoproteins | |
30.30.220.70: Coagulation factors | |
30.30.220.80: Conjugated proteins | |
30.30.220.90: Contractile proteins | |
30.30.220: Proteins | |
30.30.230: Small molecules | |
30.30.30: Bioelectromagnetism | |
30.30.40.10: Energy-producing organelles | |
30.30.40.20: Energy-producing processes | |
30.30.40: Bioenergetics | |
30.30.50: Bioinorganic chemistry | |
30.30.60: Biomacromolecule-ligand interactions | |
30.30.70: Blood chemistry | |
30.30.80: Chemical biology | |
30.30.90: Cofactors | |
30.30: Biochemistry | |
30.40.10: Animal studies | |
30.40.20: Justice in science | |
30.40.30: Respecting human dignity | |
30.40.40: Risk-benefit analysis | |
30.40.50: Sanctity of life | |
30.40.60: Scientific beneficence | |
30.40.70: Scientific nonmaleficence | |
30.40: Bioethics | |
30.50.100.10: Radiation effects | |
30.50.100.20: Radiation exposure | |
30.50.100.30: Radioprotection | |
30.50.100.40: Radiotherapy | |
30.50.100: Radiation biophysics | |
30.50.10: Biomacromolecule-ligand interactions | |
30.50.20.10: Biological fluid mechanics | |
30.50.20.20: Bone and joint mechanics | |
30.50.20.30: Cell mechanics | |
30.50.20.40: Flight mechanics | |
30.50.20.50: Tissue mechanics | |
30.50.20: Biomechanics | |
30.50.30: Biophysics simulations | |
30.50.40: Biophysics theory | |
30.50.50.10: Actin filaments | |
30.50.50.20: Ciliary movement | |
30.50.50.30: Electromotility | |
30.50.50.40: Flagellar motility | |
30.50.50.50: Microtubules | |
30.50.50: Cell motility | |
30.50.60: Macromolecular assemblies | |
30.50.70.10.100: Forms of DNA | |
30.50.70.10.10: Complementary DNA | |
30.50.70.10.20: DNA amplification | |
30.50.70.10.30: DNA metabolism | |
30.50.70.10.40: DNA modification | |
30.50.70.10.50: DNA recombination | |
30.50.70.10.60: DNA repair | |
30.50.70.10.70: DNA replication | |
30.50.70.10.80: DNA structure | |
30.50.70.10.90: DNA synthesis | |
30.50.70.10: DNA | |
30.50.70.20: Nucleic acid components | |
30.50.70.30: Nucleotides | |
30.50.70.40.10: RNA interference | |
30.50.70.40.20: RNA processing | |
30.50.70.40.30: RNA stability | |
30.50.70.40.40: RNA structure | |
30.50.70.40.50: RNA synthesis | |
30.50.70.40.60: RNA transport | |
30.50.70.40: RNA | |
30.50.70.50: Ribozymes | |
30.50.70.60.10: Glycol nucleic acids | |
30.50.70.60.20: Locked nucleic acids | |
30.50.70.60.30: Morpholino | |
30.50.70.60.40: Peptide nucleic acids | |
30.50.70.60.50: Threose nucleic acids | |
30.50.70.60: Synthetic nucleic acids | |
30.50.70: Nucleic acids | |
30.50.80: Protein chemistry | |
30.50.90: Protein folding | |
30.50: Biophysics | |
30.60.100: Pharmacogenomics | |
30.60.10: Applied microbiology | |
30.60.110.10: Genetically modified organisms | |
30.60.110.20: Marker-assisted selection | |
30.60.110.30: Transgenic plants | |
30.60.110: Plant biotechnology | |
30.60.120: Small molecules | |
30.60.130: Tissue engineering | |
30.60.20: Biocatalysis | |
30.60.30: Bioeconomy | |
30.60.40.10: Biological systems engineering | |
30.60.40.20: Biomedical engineering | |
30.60.40.30: Biomimetics | |
30.60.40.40: Bionics | |
30.60.40.50: Medical devices | |
30.60.40: Bioengineering | |
30.60.50: Biomaterials | |
30.60.60: Bionanotechnology | |
30.60.70: Drug discovery | |
30.60.80.10: Biodegradation | |
30.60.80.20: Bioremediation | |
30.60.80: Environmental biotechnology | |
30.60.90.10: Genetically modified foods | |
30.60.90.20: Genetically modified organisms | |
30.60.90.30: Transgenics | |
30.60.90: Genetic engineering | |
30.60: Biotechnology | |
30.70.100: Metabolic networks | |
30.70.10: Bio-ontologies | |
30.70.110: Microarrays | |
30.70.120.10: Gene classes | |
30.70.120.20: Gene duplication | |
30.70.120.30: Gene identification and analysis | |
30.70.120.40: Gene regulation | |
30.70.120.50: Gene expression | |
30.70.120: Molecular genetics | |
30.70.130: Natural language processing | |
30.70.140.100: Ploidy | |
30.70.140.10: Effective population size | |
30.70.140.20: Gene flow | |
30.70.140.30: Gene pool | |
30.70.140.40: Genetic drift | |
30.70.140.50: Genetic polymorphism | |
30.70.140.60: Haplotypes | |
30.70.140.70: Mutation | |
30.70.140.80: Natural selection | |
30.70.140.90: Neutral theory | |
30.70.140: Population genetics | |
30.70.150.10: Infectious disease modeling | |
30.70.150: Population modeling | |
30.70.160: Regulatory networks | |
30.70.170: Sequence analysis | |
30.70.180: Signaling networks | |
30.70.190: Synthetic biology | |
30.70.200: Systems biology | |
30.70.20: Biochemical simulations | |
30.70.210: Text mining | |
30.70.30: Biological data management | |
30.70.40: Biophysic al simulations | |
30.70.50.10: Circuit models | |
30.70.50.20: Coding mechanisms | |
30.70.50.30: Sensory systems | |
30.70.50.40: Single neuron function | |
30.70.50: Computational neuroscience | |
30.70.60: Ecosystem modeling | |
30.70.70: Evolutionary modeling | |
30.70.80.100: Metagenomics | |
30.70.80.10: Comparative genomics | |
30.70.80.110: Pharmacogenomics | |
30.70.80.120: Physiogenomics | |
30.70.80.130: Structural genomics | |
30.70.80.140: Structure prediction | |
30.70.80.20: Epigenomics | |
30.70.80.30: Functional genomics | |
30.70.80.40.100: Spacer regions | |
30.70.80.40.10: Gene ontologies | |
30.70.80.40.110: Trait locus analysis | |
30.70.80.40.120: Transcriptomes | |
30.70.80.40.20: Gene prediction | |
30.70.80.40.30: Genetic maps | |
30.70.80.40.40: Genetic networks | |
30.70.80.40.50: Genetic screens | |
30.70.80.40.60: Genome scans | |
30.70.80.40.70: Genome-wide association studies | |
30.70.80.40.80: Linkage maps | |
30.70.80.40.90: Sequence assembly tools | |
30.70.80.40: Genome analysis tools | |
30.70.80.50: Genome complexity | |
30.70.80.60: Genome databases | |
30.70.80.70: Genome evolution | |
30.70.80.80: Genome expression analysis | |
30.70.80.90: Genome sequencing | |
30.70.80: Genomics | |
30.70.90.10: DNA structure | |
30.70.90.20: Lipid structure | |
30.70.90.30: Macromolecular complex analysis | |
30.70.90.40: Protein structure | |
30.70.90.50: RNA structure | |
30.70.90: Macromolecular structure analysis | |
30.70: Computational biology | |
30.80: Cryobiology | |
30.90.100.10: Aging | |
30.90.100.20: Metamorphosis | |
30.90.100.30: Organogenesis | |
30.90.100.40: Pattern formation | |
30.90.100.50: Regeneration | |
30.90.100.60: Teratology | |
30.90.100: Organism development | |
30.90.10: Cell differentiation | |
30.90.110: Pattern formation | |
30.90.120: Plant growth and development | |
30.90.130.10: Adult stem cells | |
30.90.130.20: Cell potency | |
30.90.130.30: Embryonic stem cells | |
30.90.130.40: Hematopoietic stem cells | |
30.90.130.50: Induced pluripotent stem cells | |
30.90.130.60: Mesenchymal stem cells | |
30.90.130.70: Neural stem cells | |
30.90.130.80: Stem cell niche | |
30.90.130.90: Stem cell lines | |
30.90.130: Stem cells | |
30.90.20: Cell fate determination | |
30.90.30: Embryology | |
30.90.40: Evolutionary developmental biology | |
30.90.50.10: Activation program | |
30.90.50.20: Sperm chemotaxis | |
30.90.50.30: Sperm-egg interactions | |
30.90.50.40: Sperm hyperactivation | |
30.90.50.50: Syngamy | |
30.90.50: Fertilization | |
30.90.60: Genomic imprinting | |
30.90.70: Microbial growth and development | |
30.90.80.10: Adhesion molecules | |
30.90.80.20: Cytokines | |
30.90.80.30: Morphogens | |
30.90.80.40: Signaling | |
30.90.80: Molecular development | |
30.90.90.100: Sex determination | |
30.90.90.10: Birth defects | |
30.90.90.110: Sexual differentiation | |
30.90.90.120: Skeletal development | |
30.90.90.20: Body plan organization | |
30.90.90.30: Cell migration | |
30.90.90.40: Genital disc | |
30.90.90.50: Growth control | |
30.90.90.60: Heart development | |
30.90.90.70: Limb development | |
30.90.90.80: Regeneration | |
30.90.90.90: Segmentation | |
30.90.90: Morphogenesis | |
30.90: Developmental biology | |
30: Biology | |
40.10.10.100: Volumetric analysis | |
40.10.10.10: Colorimetric analysis | |
40.10.10.110: Water analysis | |
40.10.10.20: Gas analysis | |
40.10.10.30: Gravimetric analysis | |
40.10.10.40: Microanalysis | |
40.10.10.50: Polarographic analysis | |
40.10.10.60: Qualitative analysis | |
40.10.10.70: Quantitative analysis | |
40.10.10.80: Radioactivation analysis | |
40.10.10.90: Titrations | |
40.10.10: Chemical analysis | |
40.100: Cosmochemistry | |
40.10: Analytical chemistry | |
40.110.10: Corrosion | |
40.110.20.100: Lasagna cells | |
40.110.20.10: Anodes | |
40.110.20.110: Primary cells | |
40.110.20.120: Salt bridges | |
40.110.20.130: Secondary cells | |
40.110.20.20: Cathodes | |
40.110.20.30: Concentration cells | |
40.110.20.40: Electrode potentials | |
40.110.20.50: Electrodes | |
40.110.20.60: Electrolytes | |
40.110.20.70: Electrolytic cells | |
40.110.20.80: Galvanic cells | |
40.110.20.90: Half-cells | |
40.110.20: Electrochemical cells | |
40.110.30: Electrolysis | |
40.110.40: Electroplating | |
40.110.50: Nernst equation | |
40.110.60: Oxidation-reduction reactions | |
40.110.70: Pourbaix diagrams | |
40.110: Electrochemistry | |
40.120.10.10: Acid deposition | |
40.120.10.20: Air quality | |
40.120.10.30: Ionospheric chemistry | |
40.120.10.40: Ozone | |
40.120.10: Atmospheric chemistry | |
40.120.20: Marine chemistry | |
40.120.30.10: Heavy metals | |
40.120.30.20: Motor oil | |
40.120.30.30: Organometallic compounds | |
40.120.30.40: Urban runoff | |
40.120.30: Pollutants | |
40.120.40.10: Anion exchange capacity | |
40.120.40.20: Cation exchange capacity | |
40.120.40: Soil chemistry | |
40.120.50.10: Acid neutralizing capacity | |
40.120.50.20: Water analysis | |
40.120.50: Water chemistry | |
40.120: Environmental chemistry | |
40.130.10: Biogeochemistry | |
40.130.20: Carbon cycle | |
40.130.30: Carbon sink | |
40.130.40: Geochronology | |
40.130: Geochemistry | |
40.140.100: VSEPR theory | |
40.140.10: Bioinorganic chemistry | |
40.140.20: Crystal field theory | |
40.140.30.10: Bioinorganic compounds | |
40.140.30.20: Cluster compounds | |
40.140.30.30: Coordination compounds | |
40.140.30.40: Main group compounds | |
40.140.30.50: Solid state compounds | |
40.140.30.60: Transition metal compounds | |
40.140.30: Inorganic compounds | |
40.140.40.10: Calcification | |
40.140.40.20: Double displacement | |
40.140.40: Inorganic reactions | |
40.140.50: Ionic bonding | |
40.140.60: Molecular symmetry group theory | |
40.140.70: Organometallic chemistry | |
40.140.80: Oxidation states | |
40.140.90: Salts | |
40.140: Inorganic chemistry | |
40.150: Medicinal chemistry | |
40.160.100.10: Metallography | |
40.160.100.20: Tractable | |
40.160.100: Physical metallurgy | |
40.160.10: Castings | |
40.160.110: Powder metallurgy | |
40.160.120: Pyrometallurgy | |
40.160.20: Deoxidation | |
40.160.30: Electroplating | |
40.160.40: Eutectics | |
40.160.50: Fiber metallurgy | |
40.160.60: Grain structures | |
40.160.70: Hydrometallurgy | |
40.160.80.100: Indium alloys | |
40.160.80.10: Bismuth alloys | |
40.160.80.110: Lead alloys | |
40.160.80.120: Magnesium alloys | |
40.160.80.130: Mercury alloys | |
40.160.80.140: Nickel alloys | |
40.160.80.150: Plutonium alloys | |
40.160.80.160: Potassium alloys | |
40.160.80.170: Rare earth alloys | |
40.160.80.180: Silver alloys | |
40.160.80.190: Soft magnetic alloys | |
40.160.80.200: Stainless steel | |
40.160.80.20: Cobalt alloys | |
40.160.80.210: Steel | |
40.160.80.220: Tin alloys | |
40.160.80.230: Titanium alloys | |
40.160.80.240: Uranium alloys | |
40.160.80.250: Zinc alloys | |
40.160.80.30: Complex metallic alloys | |
40.160.80.40: Copper alloys | |
40.160.80.50: Ferroalloys | |
40.160.80.60: Iron alloys | |
40.160.80.70: Aluminum alloys | |
40.160.80.80: Gallium alloys | |
40.160.80.90: Gold alloys | |
40.160.80: Metal alloys | |
40.160.90: Metal segregation | |
40.160: Metallurgy | |
40.170.10: Nuclides | |
40.170.20: Radiation chemistry | |
40.170: Nuclear chemistry | |
40.180.10.100: Hydroxamic acids | |
40.180.10.10: Aliphatic acids | |
40.180.10.110: Kojic acid | |
40.180.10.120: Phosphinic acids | |
40.180.10.130: Phosphonic acids | |
40.180.10.140: Picramic acid | |
40.180.10.150: Picric acid | |
40.180.10.160: Pyruvic acid | |
40.180.10.170: Retinoic acids | |
40.180.10.180: Styphnic acids | |
40.180.10.190: Sugar acids | |
40.180.10.200: Sulfamic acids | |
40.180.10.20: Amino acids | |
40.180.10.210: Sulfinic acids | |
40.180.10.220: Sulfonic acids | |
40.180.10.30: Barbituric acids | |
40.180.10.40: Butyric acids | |
40.180.10.50: Carboxylic acids | |
40.180.10.60: Dibasic organic acids | |
40.180.10.70: Glycolic acid | |
40.180.10.80: Gymnemic acid | |
40.180.10.90: Hippuric acid | |
40.180.10: Organic acids | |
40.180.20.100: Alkynes | |
40.180.20.10: Acid anhydrides | |
40.180.20.110: Amides | |
40.180.20.120: Amines | |
40.180.20.130: Arenes | |
40.180.20.140: Aromatic hydrocarbons | |
40.180.20.150: Butanol | |
40.180.20.160: Chromophores | |
40.180.20.170: Cycloalkanes | |
40.180.20.180: Diazo compounds | |
40.180.20.190: Epoxides | |
40.180.20.200: Esters | |
40.180.20.20: Acyl halides | |
40.180.20.210: Ethanol | |
40.180.20.220: Ethers | |
40.180.20.230: Functional groups | |
40.180.20.240: Hydrocarbons | |
40.180.20.250: Imines | |
40.180.20.260: Ketones | |
40.180.20.270: Methanol | |
40.180.20.280: Nitriles | |
40.180.20.290: Nitroalkanes | |
40.180.20.300: Nitrogen heterocyclic compounds | |
40.180.20.30: Alcohols | |
40.180.20.310: Nitroso compounds | |
40.180.20.320: Organic nitrogen compounds | |
40.180.20.330: Organic sulfur compounds | |
40.180.20.340: Organometallic compounds | |
40.180.20.350: Organophosphates | |
40.180.20.360: Oximes | |
40.180.20.370: Phosphorothioates | |
40.180.20.380: Propanol | |
40.180.20.390: Small molecules | |
40.180.20.400: Terpenes | |
40.180.20.40: Aldehydes | |
40.180.20.410: Thiols | |
40.180.20.420: Thymidines | |
40.180.20.50: Alkadienes | |
40.180.20.60: Alkaloids | |
40.180.20.70: Alkanes | |
40.180.20.80: Alkenes | |
40.180.20.90: Alkyl halides | |
40.180.20: Organic compounds | |
40.180.30.100: Vegetable oils | |
40.180.30.10: Coal | |
40.180.30.110: Waxes | |
40.180.30.20: Cork | |
40.180.30.30: Creosote | |
40.180.30.40: Feathers | |
40.180.30.50: Fur | |
40.180.30.60: Leather | |
40.180.30.70: Petroleum products | |
40.180.30.80: Pitch | |
40.180.30.90: Straw | |
40.180.30: Organic materials | |
40.180.40: Organic radicals | |
40.180.50.10: Acylation | |
40.180.50.20: Curing | |
40.180.50.30: Dehydrogenation | |
40.180.50.40: Diels-Alder reaction | |
40.180.50.50: Friedel-Crafts reactions | |
40.180.50.60: Hydrogenation | |
40.180.50.70: Metalation | |
40.180.50.80: Polymerization | |
40.180.50.90: Transesterification | |
40.180.50: Organic reactions | |
40.180.60: Organic synthesis | |
40.180.70: Organometallic chemistry | |
40.180.80: Physical organic chemistry | |
40.180: Organic chemistry | |
40.190: Petrochemistry | |
40.20.10.100: Heat of reaction | |
40.20.10.10: Amphiphilicity | |
40.20.10.110: Intermolecular forces | |
40.20.10.120: Latent heat | |
40.20.10.130: Lipophilia | |
40.20.10.140: Nuclear magnetic resonance | |
40.20.10.150: Permeability | |
40.20.10.160: pH factor | |
40.20.10.170: Photochromism | |
40.20.10.180: Physicochemical properties | |
40.20.10.190: Salinity | |
40.20.10.200: Specific gravity | |
40.20.10.20: Anisotropy | |
40.20.10.210: Surface properties | |
40.20.10.220: Viscosity | |
40.20.10.30: Calorific value | |
40.20.10.40: Dimerization | |
40.20.10.50: Electron affinity | |
40.20.10.60: Heat of activation | |
40.20.10.70: Heat of combustion | |
40.20.10.80: Heat of formation | |
40.20.10.90: Heat of fusion | |
40.20.10: Chemical properties | |
40.20.20.100: Sulfonyl radicals | |
40.20.20.10: Butyl radicals | |
40.20.20.110: Uranyl radicals | |
40.20.20.120: Zirconyl radicals | |
40.20.20.20: Carboxyl radicals | |
40.20.20.30: Chromyl radicals | |
40.20.20.40: Hexyl radicals | |
40.20.20.50: Hydroxyl radicals | |
40.20.20.60: Nitro radicals | |
40.20.20.70: Octyl radicals | |
40.20.20.80: Organic radicals | |
40.20.20.90: Perchloryl radicals | |
40.20.20: Chemical radicals | |
40.200.10.10: Covalent bonding | |
40.200.10.20: Cross-linking | |
40.200.10.30: Dipole-dipole interactions | |
40.200.10.40: Hydrogen bonding | |
40.200.10.50: Ionic bonding | |
40.200.10.60: London dispersion forces | |
40.200.100: Ion exchange | |
40.200.10: Chemical bonding | |
40.200.110: Liquid-state dynamics | |
40.200.120.10: Aerosols | |
40.200.120.20: Colloids | |
40.200.120.30: Heterogeneous mixtures | |
40.200.120.40: Homogeneous mixtures | |
40.200.120.50: Solutions | |
40.200.120.60: Suspensions | |
40.200.120: Mixtures | |
40.200.130.10: Grotthuss-Draper law | |
40.200.130.20: Photographic sensitizers | |
40.200.130.30: Solar photochemistry | |
40.200.130.40: Stark-Einstein law | |
40.200.130: Photochemistry | |
40.200.140: Physical organic chemistry | |
40.200.150: Proton-motive force | |
40.200.160: Quasi-bound states | |
40.200.170.10: Femtochemistry | |
40.200.170.20: Gibbs free energy | |
40.200.170.30: Reaction kinetics | |
40.200.170.40: Reaction quotient | |
40.200.170.50: Reactivity series | |
40.200.170.60: Transition state | |
40.200.170: Reaction dynamics | |
40.200.180: Sorption | |
40.200.190: Surface chemistry | |
40.200.200.10: Enthalpy | |
40.200.200.20: Entropy | |
40.200.200.30: Gibbs free energy | |
40.200.200.40: Volatilization | |
40.200.200: Thermodynamics | |
40.200.20: Chemical dynamics | |
40.200.30: Chemical equilibrium | |
40.200.40.100: Heat of reaction | |
40.200.40.10: Amphiphilicity | |
40.200.40.110: Intermolecular forces | |
40.200.40.120: Latent heat | |
40.200.40.130: Lipophilia | |
40.200.40.140: Nuclear magnetic resonance | |
40.200.40.150: Permeability | |
40.200.40.160: pH factor | |
40.200.40.170: Photochromism | |
40.200.40.180: Physicochemical properties | |
40.200.40.190: Salinity | |
40.200.40.200: Specific gravity | |
40.200.40.20: Anisotropy | |
40.200.40.210: Surface properties | |
40.200.40.220: Viscosity | |
40.200.40.30: Calorific value | |
40.200.40.40: Dimerization | |
40.200.40.50: Electron affinity | |
40.200.40.60: Heat of activation | |
40.200.40.70: Heat of combustion | |
40.200.40.80: Heat of formation | |
40.200.40.90: Heat of fusion | |
40.200.40: Chemical properties | |
40.200.50.100: Sulfonyl radicals | |
40.200.50.10: Butyl radicals | |
40.200.50.110: Uranyl radicals | |
40.200.50.20: Carboxyl radicals | |
40.200.50.220: Zirconyl radicals | |
40.200.50.30: Chromyl radicals | |
40.200.50.40: Hexyl radicals | |
40.200.50.50: Hydroxyl radicals | |
40.200.50.60: Nitro radicals | |
40.200.50.70: Octyl radicals | |
40.200.50.80: Organic radicals | |
40.200.50.90: Perchloryl radicals | |
40.200.50: Chemical radicals | |
40.200.60: Deposition | |
40.200.70: Energy transfer | |
40.200.80: Gaussian fluctuations | |
40.200.90: Hydrogen-ion concentration | |
40.200: Physical chemistry | |
40.20: Applied chemistry | |
40.210.10: Phytochemicals | |
40.210.20: Phytopharmacology | |
40.210: Phytochemistry | |
40.220.10: Monomers | |
40.220.20: Polymerization | |
40.220: Polymer chemistry | |
40.230: Quantum chemistry | |
40.240.10: Hot atom chemistry | |
40.240.20: Isotopes | |
40.240.30: Nuclear decay | |
40.240.40: Radioactivity | |
40.240: Radiochemistry | |
40.250: Reprographic processes | |
40.260.100: Kinetic resolution | |
40.260.10: Anomeric effect | |
40.260.110: Molecular conformation | |
40.260.120: Mutarotation | |
40.260.130: Pseudorotation | |
40.260.140: Ring inversion | |
40.260.150: Rotations | |
40.260.160: Stereoconvergence | |
40.260.170: Stereomutation | |
40.260.180: Stereoselectivity | |
40.260.190: Stereospecificity | |
40.260.200: Strains | |
40.260.20: Asymmetry | |
40.260.210: Topomerization | |
40.260.30: Bond angles | |
40.260.40: Constitutional isomers | |
40.260.50: Desymmetrization | |
40.260.60: Fischer projection | |
40.260.70: Gauche effect | |
40.260.80: Isomerism | |
40.260.90: Isomerization | |
40.260: Stereochemistry | |
40.270.10: Coinage metal-catalyzed reactions | |
40.270.20: Heterocycle structures | |
40.270.30: Heterocycle synthesis | |
40.270.40: Organic synthesis | |
40.270: Synthetic chemistry | |
40.280: Theoretical chemistry | |
40.30.10: Acid deposition | |
40.30.20: Air quality | |
40.30.30: Ionospheric chemistry | |
40.30.40: Ozone | |
40.30: Atmospheric chemistry | |
40.40.10: Chemical production | |
40.40.20: Industrial chemicals | |
40.40: Chemical engineering | |
40.50: Chemical biology | |
40.60: Chemical physics | |
40.70.100: Double displacement | |
40.70.10: Addition reactions | |
40.70.110: Elimination reactions | |
40.70.120: Endothermic reactions | |
40.70.130: Exchange reactions | |
40.70.140: Exothermic reactions | |
40.70.150: Friedel crafts reactions | |
40.70.160: Glycerolization | |
40.70.170: Halogenation | |
40.70.180: Hydrogenation | |
40.70.190: Hydrolysis | |
40.70.200.10: Anions | |
40.70.200.20: Cations | |
40.70.200.30: Isomerization | |
40.70.200: Ionization | |
40.70.20: Belousov-Zhabotinsky reaction | |
40.70.210: Maillard reaction | |
40.70.220: Metalation | |
40.70.230: Neutralization | |
40.70.240: Nitration | |
40.70.250: Nitrification | |
40.70.260: Nitrofluorination | |
40.70.270.10: Acylation | |
40.70.270.20: Curing | |
40.70.270.30: Dehydrogenation | |
40.70.270.40: Diels-Alder reaction | |
40.70.270.50: Friedel-Crafts reactions | |
40.70.270.60: Hydrogenation | |
40.70.270.70: Metalation | |
40.70.270.80: Polymerization | |
40.70.270.90: Transesterification | |
40.70.270: Organic reactions | |
40.70.280: Oxidation-reduction reactions | |
40.70.290: Photochemical reactions | |
40.70.300: Polymerization | |
40.70.30: Calcification | |
40.70.310: Precipitation (chemistry) | |
40.70.320: Recombination reactions | |
40.70.330: Schoenemann reactions | |
40.70.340: Separation | |
40.70.350: Side reactions | |
40.70.360: Solvation | |
40.70.370.10: Alcoholysis | |
40.70.370.20: Ammonolysis | |
40.70.370.30: Hydrolysis | |
40.70.370: Solvolysis | |
40.70.380: Substitution reactions | |
40.70.390: Sulfation | |
40.70.40.10: Biocatalysis | |
40.70.40.20: Desulfurization | |
40.70.40.30: Electrocatalysts | |
40.70.40.40: Heterogeneous catalysts | |
40.70.40.50: Homogeneous catalysts | |
40.70.40.60: Organocatalysis | |
40.70.400: Sulfuration | |
40.70.40: Catalysis | |
40.70.410: Surface reactions | |
40.70.420: Synthesis | |
40.70.50: Chelation | |
40.70.60.100: Pechmann condensation | |
40.70.60.10: Acyloin condensation | |
40.70.60.110: Rap-Stoermer condensation | |
40.70.60.120: Symmetrical aldol condensation | |
40.70.60.130: Ziegler condensation | |
40.70.60.20: Aldol condensation | |
40.70.60.30: Claisen condensation | |
40.70.60.40: Claisen-Schmidt condensation | |
40.70.60.50: Darzens condensation | |
40.70.60.60: Dieckmann condensation | |
40.70.60.70: Guareschi-Thorpe condensation | |
40.70.60.80: Knoevenagel condensation | |
40.70.60.90: Michael condensation | |
40.70.60: Condensation reactions | |
40.70.70: Curing | |
40.70.80: Dehydrogenation | |
40.70.90: Dissociation | |
40.70: Chemical reactions | |
40.80.100: Simulated moving-bed chromatography | |
40.80.10: Affinity chromatography | |
40.80.110: Size exclusion chromatography | |
40.80.120: Supercritical fluid chromatography | |
40.80.130: Thin layer chromatography | |
40.80.140: Two-dimensional chromatography | |
40.80.20: Chiral chromatography | |
40.80.30: Column chromatography | |
40.80.40: Gas chromatography | |
40.80.50: Ion exchange chromatography | |
40.80.60: Liquid chromatography | |
40.80.70: Paper chromatography | |
40.80.80: Planar chromatography | |
40.80.90: Reversed-phase chromatography | |
40.80: Chromatography | |
40.90.10: Ab initio methods | |
40.90.20: Density functional theory | |
40.90.30: Empirical methods | |
40.90.40: Molecular dynamics | |
40.90.50: Molecular mechanics | |
40.90.60: Semi-empirical methods | |
40.90: Computational chemistry | |
40: Chemistry | |
50.100: Cryptography | |
50.10: Algorithms | |
50.110.10: Environmental systems modeling | |
50.110.20: Geocomputation | |
50.110.30: Geostatistics | |
50.110.40: Modifiable areal unit | |
50.110.50: Remote sensing imagery | |
50.110.60: Spatial autocorrelation | |
50.110: Geoinformatics | |
50.120.10: Databases | |
50.120: Information technology | |
50.130: Natural language processing | |
50.140: Numerical analysis | |
50.150: Ontology and logics | |
50.160.10: Assembly languages | |
50.160.20: High level languages | |
50.160.30: Simulation languages | |
50.160: Programming languages | |
50.170.10: Computer benchmarking | |
50.170.20: Constructive research | |
50.170.30: Fault tolerance | |
50.170.40: Software design | |
50.170.50: Software tools | |
50.170: Software engineering | |
50.180: Synthetic vision systems | |
50.190: Text mining | |
50.20.10: Computer-aided design | |
50.20.20: Computer-aided manufacturing | |
50.20.30: Computer-assisted instruction | |
50.20.40: Web-based applications | |
50.20: Computer applications | |
50.30.10: Computer hardware | |
50.30.20: Linking design | |
50.30: Computer architecture | |
50.40: Computer modeling | |
50.50: Computer security | |
50.60: Computerized simulations | |
50.70.10: Cloud computing | |
50.70.20: Computer animation | |
50.70.30: Computer graphics | |
50.70.40: Computer inferencing | |
50.70.50: Fuzzy logic | |
50.70.60: Mathematical computing | |
50.70: Computing methods | |
50.80.10: Analog computing | |
50.80.20: Digital computing | |
50.80.30: Hybrid computing | |
50.80.40: Molecular computing | |
50.80.50: Optical computing | |
50.80.60: Quantum computing | |
50.80.70: Spintronics | |
50.80: Computing systems | |
50.90.10: Control systems | |
50.90.20: Fault tolerance | |
50.90: Control engineering | |
50: Computer science | |
60.10.10.10: Acid deposition | |
60.10.10.20: Air quality | |
60.10.10.30: Ionospheric chemistry | |
60.10.10.40: Ozone | |
60.10.10: Atmospheric chemistry | |
60.10.20.10: Atmospheric circulation | |
60.10.20.20: Atmospheric clouds | |
60.10.20.30: Atmospheric dispersion modeling | |
60.10.20.40: Atmospheric storms | |
60.10.20: Atmospheric dynamics | |
60.10.30.10: Atmospheric corona | |
60.10.30.20: Atmospheric glow | |
60.10.30.30: Aurora | |
60.10.30.40: Brocken bow | |
60.10.30.50: Cellini's halo | |
60.10.30.60: Lightening | |
60.10.30.70: Parhelion | |
60.10.30.80: Transient luminous events | |
60.10.30: Atmospheric phenomena | |
60.10.40: Atmospheric physics | |
60.10.50.10: Exosphere | |
60.10.50.20: Heterosphere | |
60.10.50.30: Homosphere | |
60.10.50.40: Ionosphere | |
60.10.50.50: Mesosphere | |
60.10.50.60: Stratosphere | |
60.10.50.70: Thermosphere | |
60.10.50.80: Troposphere | |
60.10.50: Atmospheric structures | |
60.10.60.10: Albedo | |
60.10.60.20: Climate change | |
60.10.60.30: Climate modeling | |
60.10.60.40: Climate record | |
60.10.60.50: Insolation | |
60.10.60.60: Paleoclimatology | |
60.10.60: Climatology | |
60.10.70: Meteorology | |
60.100.10: Glaciers | |
60.100.20: Ice cap | |
60.100.30: Ice core | |
60.100.40: Ice sheet | |
60.100.50: Ice shelf | |
60.100.60: Meltwater | |
60.100.70: Polynyas | |
60.100.80: Sea ice | |
60.100: Glaciology | |
60.10: Atmospheric science | |
60.110.10: Limnetic ecology | |
60.110.20: Limnetic ecosystem | |
60.110.30: Limnogeology | |
60.110.40: Paleolimnology | |
60.110.50: Physical limnology | |
60.110: Limnology | |
60.120.100.100: Tethys | |
60.120.100.10: Antarctic Ocean | |
60.120.100.20: Arctic Ocean | |
60.120.100.30: Atlantic Ocean | |
60.120.100.40: Equatorial Ocean | |
60.120.100.50: Gulf of Alaska | |
60.120.100.60: Gulf of Mexico | |
60.120.100.70: Indian Ocean | |
60.120.100.80: Mediterranean Sea | |
60.120.100.90: Pacific Ocean | |
60.120.100: Oceans | |
60.120.10: Coastal ecology | |
60.120.110.10: Biochemical oxygen demand | |
60.120.110.20: Chemical oxygen demand | |
60.120.110.30: Dissolved oxygen | |
60.120.110.40: Heavy metals | |
60.120.110.50: pH factor | |
60.120.110.60: Total dissolved solids | |
60.120.110: Water quality | |
60.120.20: Freshwater ecology | |
60.120.30: Hydrology | |
60.120.40: Marine biology | |
60.120.50: Marine ecology | |
60.120.60.10: Cold seeps | |
60.120.60.20: Hydrothermal vents | |
60.120.60.30: Ocean basins | |
60.120.60.40: Ocean floor | |
60.120.60.50: Ocean ridges | |
60.120.60.60: Ocean troughs | |
60.120.60.70: Sediment | |
60.120.60.80: Spreading centers | |
60.120.60: Marine geology | |
60.120.70: Marine monitoring | |
60.120.80: Marine technology | |
60.120.90.100: Physical oceanography | |
60.120.90.10: Biological oceanography | |
60.120.90.110: Sea level change | |
60.120.90.120: Seafloor spreading | |
60.120.90.130: Water column | |
60.120.90.20: Chemical oceanography | |
60.120.90.30: El Nino Southern Oscillation | |
60.120.90.40: Geological oceanography | |
60.120.90.50: La Nina | |
60.120.90.60: Ocean circulation | |
60.120.90.70: Ocean properties | |
60.120.90.80: Ocean temperature | |
60.120.90.90: Paleooceanography | |
60.120.90: Oceanography | |
60.120: Marine and aquatic sciences | |
60.130.10: Clay mineralogy | |
60.130.20: Coesite | |
60.130.30: Mineral deposits | |
60.130.40: Minerals | |
60.130: Mineralogy | |
60.140.100: Vertebrate paleontology | |
60.140.10: Biogeography | |
60.140.20: Biostratigraphy | |
60.140.30: Invertebrate paleontology | |
60.140.40: Micropaleontology | |
60.140.50: Paleobiology | |
60.140.60: Paleobotany | |
60.140.70: Paleoclimatology | |
60.140.80: Paleoecology | |
60.140.90: Taphonomy | |
60.140: Paleontology | |
60.150.10: Atmosphere | |
60.150.20: Biosphere | |
60.150.30: Geographical hydrology | |
60.150.40: Hydrosphere | |
60.150: Physical geography | |
60.20.10: Earth core | |
60.20.20: Earth crust | |
60.20.30: Earth mantle | |
60.20.40: Lithosphere | |
60.20.50: Mohorovicic discontinuity | |
60.20.60: Oceanic crust | |
60.20.70: Regolith | |
60.20: Earth | |
60.30.10.10: Hydroelectric power | |
60.30.10.20: Photovoltaic power | |
60.30.10.30: Wind power | |
60.30.10: Alternative energy | |
60.30.20: Bioenergy | |
60.30.30.10: Bioalcohols | |
60.30.30.20: Biodiesel | |
60.30.30.30: Bioethers | |
60.30.30.40: Biogas | |
60.30.30.50: Green diesel | |
60.30.30.60: Solid biofuels | |
60.30.30.70: Syngas | |
60.30.30.80: Vegetable oils | |
60.30.30: Biofuels | |
60.30.40.10: Crude oil | |
60.30.40.20: Diesel fuel | |
60.30.40.30: Gasoline | |
60.30.40.40: Natural gas | |
60.30.40: Fossil fuels | |
60.30.50: Fuels | |
60.30.60.10: Electric power distribution | |
60.30.60.20: Electric power transmission | |
60.30.60: Power distribution | |
60.30: Energy and power | |
60.40.10.10: Hazardous wastes | |
60.40.10.20: Nuclear waste | |
60.40.10.30: Oil spills | |
60.40.10.40: Pollution | |
60.40.10.50: Solid waste management | |
60.40.10.60: Water management | |
60.40.10: Environmental engineering | |
60.40.20: Environmental economics | |
60.40.30: Environmental geography | |
60.40.40: Environmental geology | |
60.40: Environmental sciences | |
60.50.10: Biogeochemistry | |
60.50.20: Carbon cycle | |
60.50.30: Carbon sink | |
60.50.40: Geochronology | |
60.50: Geochemistry | |
60.60.10: Biogeography | |
60.60.20.10: Elevations | |
60.60.20.20: GIS | |
60.60.20.30: Isotherms | |
60.60.20.40: Latitude | |
60.60.20.50: Longitude | |
60.60.20.60: Remote sensing imagery | |
60.60.20: Cartography | |
60.60.30.10: Behavioral matrix | |
60.60.30.20: Economic man | |
60.60.30.30: Isodapanes | |
60.60.30.40: Satisficer | |
60.60.30.50: Spatial economic analysis | |
60.60.30: Economic geography | |
60.60.40.10: Environmental systems modeling | |
60.60.40.20: Geocomputation | |
60.60.40.30: Geostatistics | |
60.60.40.40: Modifiable areal unit | |
60.60.40.50: Remote sensing imagery | |
60.60.40.60: Spatial autocorrelation | |
60.60.40: Geoinformatics | |
60.60.50.10: Erosion | |
60.60.50.20: Landform dynamics | |
60.60.50.30: Landform history | |
60.60.50.40: Surface earth movement | |
60.60.50: Geomorphology | |
60.60.60: Geosystems | |
60.60.70.100: Social geography | |
60.60.70.10: Behavioral geography | |
60.60.70.110: Spatial analysis | |
60.60.70.20: Central-place theory | |
60.60.70.30: Cultural geography | |
60.60.70.40: Distance-decay models | |
60.60.70.50: Historical geography | |
60.60.70.60: Least-cost location | |
60.60.70.70: Nature and society interactions | |
60.60.70.80: Regional geography | |
60.60.70.90: Settlement patterns | |
60.60.70: Human geography | |
60.60.80.10: Atmosphere | |
60.60.80.20: Biosphere | |
60.60.80.30: Geographical hydrology | |
60.60.80.40: Hydrosphere | |
60.60.80: Physical geography | |
60.60.90: Political geography | |
60.60: Geography | |
60.70.10.10: Cenozoic | |
60.70.10.20: Phanerozoic | |
60.70.10.30: Precambrian | |
60.70.100: Structural geology | |
60.70.10: Geologic time | |
60.70.110: Volcanology | |
60.70.20: Historical geology | |
60.70.30: Igneous geology | |
60.70.40: Metamorphic geology | |
60.70.50.10: Anatexis | |
60.70.50.20: Facies metamorphism | |
60.70.50.30: Metasomatism | |
60.70.50.40: Petrogenesis | |
60.70.50.50: Rock units | |
60.70.50: Petrology | |
60.70.60: Planetary geology | |
60.70.70: Plate tectonics | |
60.70.80: Sedimentary geology | |
60.70.90.10: Biostratigraphy | |
60.70.90.20: Lithostratigraphy | |
60.70.90: Stratigraphy | |
60.70: Geology | |
60.80.10: Erosion | |
60.80.20: Landform dynamics | |
60.80.30: Landform history | |
60.80.40: Surface earth movement | |
60.80: Geomorphology | |
60.90.10: Earthshine | |
60.90.20: Geodesy | |
60.90.30: Geoelectricity | |
60.90.40: Geomagnetism | |
60.90.50: Seismology | |
60.90: Geophysics | |
60: Earth sciences | |
70.10.100.10: Internal combustion engines | |
70.10.100.20: Jet engines | |
70.10.100.30: Rockets | |
70.10.100.40: Spacecraft propulsion | |
70.10.100.50: Turbomachinery | |
70.10.100: Propulsion | |
70.10.10: Aeroelasticity | |
70.10.20: Aeronautical engineering | |
70.10.30: Astrodynamics | |
70.10.40.10: Aerospace systems | |
70.10.40.20: Atmospheric reentry | |
70.10.40: Astronautics | |
70.10.50: Aviation | |
70.10.60: Avionics | |
70.10.70: Flight testing | |
70.10.80: Fluid mechanics | |
70.10.90: Noise control | |
70.100.10: Hazardous wastes | |
70.100.20: Nuclear waste | |
70.100.30: Oil spills | |
70.100.40: Pollution | |
70.100.50: Solid waste management | |
70.100.60: Water management | |
70.100: Environmental engineering | |
70.10: Aerospace engineering | |
70.110.10: Fire research | |
70.110.20: Fire safety | |
70.110.30: Fire suppression technology | |
70.110.40: Smoke | |
70.110: Fire engineering | |
70.120: Forensic engineering | |
70.130: Geological engineering | |
70.140.10: Ergonomics | |
70.140.20: Habitability | |
70.140.30.10: Graphical user interface | |
70.140.30.20: Virtual reality | |
70.140.30: Man computer interface | |
70.140: Human factors engineering | |
70.150: Industrial ecology | |
70.160.10: Industrial modernization | |
70.160.20: Industrial preparedness | |
70.160.30: Industrial research | |
70.160.40: Nuclear industrial applications | |
70.160.50: Process engineering | |
70.160.60: Spinning (industrial processes) | |
70.160: Industrial engineering | |
70.170.10.10: Organizational realignment | |
70.170.10.20: Outsourcing | |
70.170.10.30: Privatization | |
70.170.10: Business process reengineering | |
70.170.20: Collaborative techniques | |
70.170.30: Management benchmarking | |
70.170.40.10: Critical path analysis | |
70.170.40.20: Gantt charts | |
70.170.40.30: Network analysis (management) | |
70.170.40.40: PERT | |
70.170.40.50: Planning programming budgeting | |
70.170.40: Management planning and control | |
70.170.50.10: Concurrent engineering | |
70.170.50.20: Mass production | |
70.170.50.30: Production control | |
70.170.50.40: Production scheduling | |
70.170.50.50: System productivity | |
70.170.50.60: Tooling | |
70.170.50: Production engineering | |
70.170: Management engineering | |
70.180.10: Seaworthiness | |
70.180.20: Shipbuilding | |
70.180: Marine engineering | |
70.190.10: Fluid mechanics | |
70.190.20: Nanoengineering | |
70.190.30: Robotics | |
70.190.40: Transportation | |
70.190.50: Vibration engineering | |
70.190: Mechanical engineering | |
70.200: Military engineering | |
70.20: Architectural engineering | |
70.210: Mining engineering | |
70.220: Nuclear engineering | |
70.230: Reliability engineering | |
70.240: Sanitary engineering | |
70.250.100: Statistical signal processing | |
70.250.10: Array processing | |
70.250.110: Video processing | |
70.250.20: Audio signal processing | |
70.250.30: Data mining | |
70.250.40: Genomic signal processing | |
70.250.50: Image processing | |
70.250.60: Quantization | |
70.250.70: Seismic signal processing | |
70.250.80: Signal filtering | |
70.250.90: Speech signal processing | |
70.250: Signal processing | |
70.260.10: Computer benchmarking | |
70.260.20: Constructive research | |
70.260.30: Fault tolerance | |
70.260.40: Software design | |
70.260.50: Software tools | |
70.260: Software engineering | |
70.270: Structural engineering | |
70.280.10: Concurrent engineering | |
70.280.20: Risk analysis | |
70.280.30: Technology assessment | |
70.280: Systems engineering | |
70.290.10.10: Debonding | |
70.290.10.20: Deformation | |
70.290.10.30: Delamination | |
70.290.10.40: Failure analysis | |
70.290.10.50: Kinematic hardening | |
70.290.10.60: Mechanical stress | |
70.290.10.70: Metal fatigue | |
70.290.10: Damage mechanics | |
70.290.20: Friction | |
70.290.30: Lubrication | |
70.290: Tribology | |
70.30.10: Biological systems engineering | |
70.30.20: Biomedical engineering | |
70.30.30: Biomimetics | |
70.30.40: Bionics | |
70.30.50: Medical devices | |
70.30: Bioengineering | |
70.40.10: Chemical production | |
70.40.20: Fluid mechanics | |
70.40.30: Industrial chemicals | |
70.40: Chemical engineering | |
70.50.10: Coastal engineering | |
70.50.20: Geotechnical engineering | |
70.50.30: Structures | |
70.50: Civil engineering | |
70.60.10: Control systems | |
70.60.20: Fault tolerance | |
70.60: Control engineering | |
70.70.10: Earthquake-resistant structures | |
70.70.20: Earthquake warning systems | |
70.70: Earthquake engineering | |
70.80.10: Computer engineering | |
70.80.20: Power engineering | |
70.80.30: Communications | |
70.80: Electrical engineering | |
70.90: Electronics engineering | |
70: Engineering | |
80.100.10: Catalytic properties | |
80.100.20: Electronic properties | |
80.100.30: Magnetic properties | |
80.100.40: Mechanical properties | |
80.100.50: Optical properties | |
80.100: Material properties | |
80.10: Biomaterials | |
80.110: Materials characterization | |
80.120: Materials chemistry | |
80.130: Materials design | |
80.140: Materials physics | |
80.150.100.10: Metallography | |
80.150.100.20: Tractable | |
80.150.100: Physical metallurgy | |
80.150.10: Castings | |
80.150.110: Powder metallurgy | |
80.150.120: Pyrometallurgy | |
80.150.20: Deoxidation | |
80.150.30: Electroplating | |
80.150.40: Eutectics | |
80.150.50: Fiber metallurgy | |
80.150.60: Grain structures | |
80.150.70: Hydrometallurgy | |
80.150.80.100: Indium alloys | |
80.150.80.10: Bismuth alloys | |
80.150.80.110: Lead alloys | |
80.150.80.120: Magnesium alloys | |
80.150.80.130: Mercury alloys | |
80.150.80.140: Nickel alloys | |
80.150.80.150: Plutonium alloys | |
80.150.80.160: Potassium alloys | |
80.150.80.170: Rare earth alloys | |
80.150.80.180: Silver alloys | |
80.150.80.190: Soft magnetic alloys | |
80.150.80.200: Stainless steel | |
80.150.80.20: Cobalt alloys | |
80.150.80.210: Steel | |
80.150.80.220: Tin alloys | |
80.150.80.230: Titanium alloys | |
80.150.80.240: Uranium alloys | |
80.150.80.250: Zinc alloys | |
80.150.80.30: Complex metallic alloys | |
80.150.80.40: Copper alloys | |
80.150.80.50: Ferroalloys | |
80.150.80.60: Iron alloys | |
80.150.80.70: Aluminum alloys | |
80.150.80.80: Gallium alloys | |
80.150.80.90: Gold alloys | |
80.150.80: Metal alloys | |
80.150.90: Metal segregation | |
80.150: Metallurgy | |
80.160: Microstructure | |
80.170: Microtechnology | |
80.180.10: Bionanotechnology | |
80.180.20: Ferritin | |
80.180.30: Molecular electronics | |
80.180.40: Nanomaterials | |
80.180.50: Nanorobotics | |
80.180.60: Programmable matter | |
80.180: Nanotechnology | |
80.190: Natural materials | |
80.200.10.10: Debonding | |
80.200.10.20: Deformation | |
80.200.10.30: Delamination | |
80.200.10.40: Failure analysis | |
80.200.10.50: Kinematic hardening | |
80.200.10.60: Mechanical stress | |
80.200.10.70: Metal fatigue | |
80.200.10: Damage mechanics | |
80.200: Tribology | |
80.20: Catalysts | |
80.210: Friction | |
80.220: Lubrication | |
80.30: Ceramography | |
80.40: Crystallography | |
80.50: Electronic materials | |
80.60: Forensic engineering | |
80.70: Glass science | |
80.80.100: Superhard materials | |
80.80.10: Energetic materials | |
80.80.20: Hazardous materials | |
80.80.30: Intelligent materials | |
80.80.40: Nanomaterials | |
80.80.50: Photonic materials | |
80.80.60: Porous materials | |
80.80.70: Reactor materials | |
80.80.80: Recording media | |
80.80.90: Smart materials | |
80.80: Material by attribute | |
80.90.100.100: Polyurethanes | |
80.90.100.10: Acrylics | |
80.90.100.110: Polyvinyl chloride | |
80.90.100.120: Synthetic polymers | |
80.90.100.130: Thermoplastics | |
80.90.100.140: Thermosetting plastics | |
80.90.100.150: Thermosetting polymers | |
80.90.100.20: Biopolymers | |
80.90.100.30: Elastomers | |
80.90.100.40: Nylons | |
80.90.100.50: Polycarbonates | |
80.90.100.60: Polyesters | |
80.90.100.70: Polyethylene | |
80.90.100.80: Polypropylene | |
80.90.100.90: Polystyrene | |
80.90.100: Polymers | |
80.90.10: Ceramics | |
80.90.110: Semiconductors | |
80.90.120: Vitreous materials | |
80.90.130: Zeolites | |
80.90.20.10: Carbon fiber | |
80.90.20.20: Fiberglass | |
80.90.20.30: Kevlar | |
80.90.20: Composite materials | |
80.90.30: Covalent crystals | |
80.90.40: Hierarchical materials | |
80.90.50.10: Coating materials | |
80.90.50.20: Dental amalgams | |
80.90.50.30: High-temperature structural materials | |
80.90.50.40: Hydrogen storage materials | |
80.90.50.50: Magnetic materials | |
80.90.50.60: Shape memory alloys | |
80.90.50.70: Superconductors | |
80.90.50: Intermetallics | |
80.90.60: Ionic crystals | |
80.90.70: Material films | |
80.90.80: Metals | |
80.90.90: Metamaterials | |
80.90: Material by structure | |
80: Materials science | |
90.10.100: Polynomials | |
90.10.10: Abstract algebra | |
90.10.110: Ring theory | |
90.10.120: Universal algebra | |
90.10.20: Algebraic equations | |
90.10.30.10: Algebraic curves | |
90.10.30.20: Elliptic curves | |
90.10.30: Algebraic geometry | |
90.10.40: Algebraic structures | |
90.10.50: Algebraic systems | |
90.10.60: Algebraic topology | |
90.10.70: Field theory | |
90.10.80: Homological algebra | |
90.10.90: Linear algebra | |
90.100.100: Stochastic processes | |
90.100.10: Bayes theorem | |
90.100.20: Central limit theorem | |
90.100.30: Events (probability theory) | |
90.100.40: Law of large numbers | |
90.100.50: Markov model | |
90.100.60: Probability density | |
90.100.70: Probability distribution | |
90.100.80: Random variables | |
90.100.90.10: Distribution curves | |
90.100.90.20: Statistical medians | |
90.100.90: Statistical distributions | |
90.100: Probability theory | |
90.10: Algebra | |
90.110.10: Biostatistics | |
90.110.20: Confidence intervals | |
90.110.30: Contingency tables | |
90.110.40: Decision theory | |
90.110.50: Statistical methods | |
90.110.60.10: Equilibrium statistical theory | |
90.110.60.20: Scaling theory | |
90.110.60: Statistical theories | |
90.110: Statistics | |
90.120.10: Algebraic topology | |
90.120.20: Cohomology | |
90.120.30: Knot theory | |
90.120.40: Manifolds | |
90.120.50: Topological invariants | |
90.120.60: Topological spaces | |
90.120: Topology | |
90.20.10: Algorithms | |
90.20.20: Complex systems | |
90.20.30: Control theory | |
90.20.40: Decision theory | |
90.20.50: Ergodic theory | |
90.20.60: Finite element analysis | |
90.20.70: Game theory | |
90.20: Applied mathematics | |
90.30.10: Differential equations | |
90.30.20: Fractional calculus | |
90.30: Calculus | |
90.40.10: Combinatorics | |
90.40.20: Computational systems | |
90.40: Discrete mathematics | |
90.50.100: Trigonometry | |
90.50.10: Computational geometry | |
90.50.20: Coordinate geometry | |
90.50.30: Differential geometry | |
90.50.40: Euclidean geometry | |
90.50.50: Fractals | |
90.50.60: Non-euclidean geometry | |
90.50.70: Projective geometry | |
90.50.80: Rigidity | |
90.50.90: Surface theory | |
90.50: Geometry | |
90.60: Mathematical computing | |
90.70.10: Brouwer fixed-point theorem | |
90.70.20: General equilibrium model | |
90.70.30: Hyperplane theorems | |
90.70.40: Pareto efficiency of general equilibrium | |
90.70: Mathematical economics | |
90.80: Nonlinear dynamics | |
90.90.10: Automorphic forms | |
90.90.20: Continued fractions | |
90.90.30: Diophantine equations | |
90.90.40: Generating functions | |
90.90.50: Number concepts | |
90.90.60: Riemann hypothesis | |
90.90.70: Special numbers | |
90.90.80: Waring's problem | |
90.90: Number theory | |
90: Mathematics |
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment